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1. EXPERIMENTAL AUTOlMMIJNE THYROmms lEAT)
1.1 EAT as ••odd for Autoi•••lllf: Tb)'f'OidDiseut (Arm)
ExperimentaJ autoimmunethyroiditis(EAT) in miceservesas an animalmodelfor the
bumanIUtoimmune thyroid disease (AlTO), Hashimoco's thyroiditis(HT) . HT wu named for
IIalwu Hashimoto(1881. 19141 thelapanese surgcon_ "firstdescribedthe disease in humans
(Klein. 1991. p. 656) . In Hr . organ-specmc T Iympboeytes specific forlhyro;d"";8ens arise.
anddue to , disorder in immunoregulation, these IUtoreac:tive clODeS arc permitted 10 proliferate
(reviewed in Volpe. 1990,p.78). Thisdefect in immunoregulation maybedue to a ....rieryof
W:tonsuchu ; lossof SlIppressor T lymphocyte functioo (Iitalcaet II.• 1988.. litalcaet II.• 1988.
Volpe. 198 1, Volpe. 1988), defectiveclonaJ activation of immatuce seIf-reactiveT and B
Iympboeytes (NossaJ. 1983), disonl" of the IIlli-icIiocyp;eetwcrk (Bunnannet II.• 198' ) or
molc:cu.1&r minUay(Ahmann et aI., 1987, Bwmannand8&lcer. 1985, lngbaret aI., 1987, Wolfet
aI.• 1988, Wenzel et aI., 1988, Weisset al., 1983l Theautoreactive T cells, specificfor thyroid
antigenssuchas thyroglobulin (Tg) andth)Toid peroxiduc(TPO ), proliferateandinteractwith
theantigen on thyroid follicularcetls (TFC) or intrathyroidaJ antigen presentingcells such as
deodritic cells (Kabele aI., 1987). Theactivation ofT cellsinducesfirst CD4+ andw er CD8+ T
cdIs thatdestroyTFC IJIdevemuaIIy the follicular ardlitecnue of the myro;dsJIDd. Antibodies
dircc:led against th)Toidantigens mayalsobeformed.and may resuh in the destruction of TFC by
lIltil>ody-depcodom cellula< cytotoxicity(ADCC) or bybUxting complement (Volpe. \990 ). The
thyroidgIaDd is an cndoainegland that syntbesiushormonessuchIS lhyroxine, whichare
essentialfor proper growth andmetabolism(Weir, 1997, pp. 295). Subsequent to immunc
desb'U<tion, thetbyro;dgWxIdocsDOtproducebonnones(or bonnoneproduction ~ reduced)
and metabolicprocessesare slowed. This results in dinicaIsymptoms in the patient.suchas
sensitivity to cold, fatiguc, and obesity andsometimes., goiter(Klein, 1997, pp. 656).
Thehistology of chronicEATis very similarto that ofHT. EATwu first desaibedby
Rose and Wltcbsky in 1956, who immunizedrabbitswith homologousthyroid extract in completc
Fmmd ' , adju_ (CFA) (Rose andWncbslcy, \956). Thisimmunization rcsuJt.,Hn both
'thyroid autoantibodiesand chanctcristic destruction ofme thyroid gland arch itecture' (Roitt, p.
315, 1994). In EAT both antibodies andT edls directed againslTg develop, resulting in thyroid
infIamnwion(Kuby. 1997. pp 486).
1.1 AIIimai Modds orEAT
Animal modelsorEATaDow the studyofme induction. manipulationandpossiblc
immunc modification ofthc pathogenic process. There aretwo types of EATmodelscurrently
under investigation, spontaneousEAT anddirect1yindue:cd EAT. In the spontaneous model of
EAT, autoimrrlmcdcsuuction oflhe thyroidglandoccurswithout cxperimcotal immune
intervention. SpontaneousEAToccursin the obese strain (OS) chicken, the Buff'a1o (BUF) and
Biobreeding(DB) rat strains, the: ArgonneLaboratoryColonyof beaglc dogsandinnon-obese
diabetic:(NOD) mousestram(B;gazz;, 1993).
1.1.1 1Dd uttd EAT
EAT canalsobeexperimental1y induced in animals by immuniution with thyroidantigens
suchas 1 8 in CFA TheinductionorEAT canbefurthersubdivided into two categories. direct
lDdindirca inductioD. Direct EAT. which is~ in animals immunized withT8 in CFA.was
pio-.d by the Roseand Wncbslcy'. experimatt. withrabbiu in 1956 (Rose Illd Wrtcbslcy,
1956). Sincethen. EAThasbeeninducedusing bothhomologousandheterologous19 in dogs
(TCfllIao e aI., 19601mo(J.... and Roitt, 19611 guineapigs (McMBtet .. aI., 1961), monkeys
(Kite et &l.t 1966) and mice (Roseet &l.t 1971). Heterologous or homologous 19 peptides have
alsobeenusedto induceEAT in miceand rats (Carayanniotis and Rao, 1997). For direct
inductionof EAT10 be sue<:essNI.!be proiein or peptidelllUSl be emu!sijjedwithCFA. Although
the precisem«hanismby which CFA enhancesthe tmmunogenicity andEAT-inducing
capabilities of 18 is unelear, CFAbasbeendescribedas havingboth inflammatory and antigen-
depot formingproperties (Weigle ClaI., 1969, Yamanaka ee al., 1992). In addi tioll to adjuVUl1, a
rangeof innateandenvironmental factorsmustalsobeconsideredin EATinduction. These
includethe geneticsusceptibility aCthehost. the antigendose. the immunization scheduleor the
route of antigm (Ag) administntioD.
In additionto the abovemethods,EATcanbe directly induced via.conjugationof normal
19 to mouseclu s 0 majorhistocompatibility complex. (MHC}-specific monoclonal antibodies
(mAb) in !beobscnceof adjuvant (BaI... and Canyanniotis. 19931) and !beplacingoffr esll
thyroids UDder the renalcapsuleor in the peritonealcavityfollowedby an intravenous(iv.)
injectionwith the: polyclonal B ccU activatorlipopolysaccaride (LPS)(Okayasu and Hatakeyama.,
1984).
Therearc alsoseveral methodsto indirectly induceEAT. Themostcommonindirect
methodis the adoptivetnnsfer of lymphoode cells(LNC) frommiceimmunized withTg or Tg
pcptides,. andfurtherstiIDlI&ted in vitro with the imm.mizing Ag. These cellsare transferredinto
naivebeatthy hostsandEAT develops2·J weekslater, A variationon this method is the induction
of'sranukmwous' EAT usingmTg.activatedspleenceOsfrommiceprimedwith LPS. The in
vitro priming of theseeeIls&!so0CQlJ'1 ill thepresmceofeitbet n...2 receptor(lL-2R) or IFN-y-
specificAbs in additionto Tg. Thisresultsin the transferof. moresevereanddestructiveformof
EAT to the naivedonon (Braley-Mullenct aI., 1991). EAT is alsoinducedafter neonatal
thymectomyofmicc, whichdisturbstheavailablepoolof lymphocytes., or thymectomyof adult
miccinc:onjunction with imdiation, whichalten the T cellsubsets(Rose, 1998).
1.3 BOlt T ctU rapoase
The murine EATmodelhasprovedveryefficientin determiningthe~
contributionofT andB cellsin EAT. Its strengths includethe factthat the murineimmunesystem
basbeene:xtensivety studied. aJongwith its MHC, manyinbredstrainsof mice.vailabJe,aDowing
for the study ofgCMticsin EAT. Using. murinemodel,VIadutiuandRose(1915)discovered
that it was T andnot B cellsthat mnsferred Tg responsivenessin 'good responder'mice.mice
that were shownto be susceptible to EA.T inductionusing TSo d:tis inferring an effectorrolefor
T cds. Subsequentstudies in other animalmodelshavesupportedthisconclusion. In the OS
chid::euspontaneous model,neorwaItbymeaomyalongwith in ""'" treatment with T ceu-
speQficantibodiesresultedin prevemionof EAT (Schauenstcin, 1998). In addition,EAT couldbe
transferred to a naive host by T cells derived frominfiltrated thyroids ofbursectomized(B cell
deprived)OS chickens. T ccIlshavebeen shownto prolifente in ....1TOin responseto mTg and
adoptivelytransferEAT to normal,naiveanimals(reviewedin KongandLewis,1990). This
dfect is abrogated by the Iddition ofTby-lllllibocly in WtTO. T cell. expanded i. WtTO by the
additionofTg havealsobeen shown to destroy thyroidmonolayen(Creemen et &I., 1983,
Salameroet II., 1985,Simonet al., 1986). Thesestudiessuggestthat T cellsplay• more
important rolethanB ccI1s in the lnitiationof EAT.
TheT cellsthatproliferatein responseto mTghavebeen shownto beCD4+ (Kong ,
1916, Simonet 11., 1985)andare H-2A-restricted (Simonet 11., 1985). The proUfentiveresponse
of T cellsin vitrocorrelateswithEAT susceptibility (Simonet 11., 1985, Okayasuet 11.,1981).
The rdativeroleofCD4+andCD8+T cellsin EAT has beenelucidatedby. smesof
experimentsby Y..chi Kongandassociates(Reviewedin KongandLewis,1990). These
experiments indicatethat CD4+ccI1s are required for the lnitiation of EAT whileboth CD4+ and
CD8+ T cellsconmbute to theseverityoftbe established disease.
Althoughthereis littleevidenceas to the cytokineprolileof infiltratingCD4+ T cells,
indirectevidenceindicatesthat they are of the T helper I (Th1) subset.Someof thisevidence
inc.ludes the hyperreactivity of peripherallymphotd c:eUs, due to the intrinsicproductionof
iDttf'kukin.2(11.-2) ill the OS chicken(reviewed in Wicket 11., 1998)andtheexacerbationof
EATby the lbl-inducing cytokinc: fi...12(Bra.ley.Mullen et al., 1998), andthe prototypicalTbl
cytokinc IFN-y(Alimiet aI., 1998). Other indim;t evidence indudesthefinding thatantibodies to
1b1C)1okines havea proIu:tNe eff'minSUSoCCptiblc snins to EAT. andthattheuscof T helper
2 (th2) cytokines such as 0...-10(Mignon..Qodeftoy et al., 1995)alsoconfer protection from
EAT. Thesestudies suppon theaurentJy bcId beliefthatThI cdlsoftencontribute to the
induction of organ-specific autoimmunity.
1. CIU+ T HELPER SUBSETS
1.1TO.. perS......
2.1.1 DdiDitiOD orT bdpcr ,ubHlI
Earlystudiesofimmune responses inmo found that infectious agentShad theability to
induce either anantibody response oracell-medialed form of immunity and that theseresponses
wereoftenassociated withdistinct e:ytokiDc pro61cs (Constant and Bottomly. 1997). It was
Mosmann et al. (1986) who6m:described two distinct subsetsofCD4+ T helpercellpopulations
as ThI andTh2,based 00 thecytokine profiles of mouseCD4+ Tcell clones {Mosmann et al,
1986}. It hassinc:e beatdisco_ that bot!lrats (East<on .. aI., 1990) andhumans(Soon et aI.,
1988)alsoexhibit these two distinct. subsets.
Thecytokine profile ofthesc two subsets has been welleharactcrizcd. Thl cellssecrete
the cy10Icines IL-2, IF!o!:r,lympI>otmcin andTNF-jl . They bavealsobeatimpUwcd... myriad of
immune responses through activation of macrcpbeges, initiation of delaycd.-type hypersensitivity
(OTH) reactionsandIgG2aandIgG) antibody production. These: includeprotectionagainst
intraceiJularpan.sites. organ--spec:ifie autoimrrwnity, aUogrUl rejection, Crohn' s diseaseand
uoexplaiDed ......... 1bortions (1lomagllllli, 1997). Th2 cellsproduce thecyIokilleIL-4,lL-S,
lL-IO and lL-1l . They arc UlVoIv<d in Intibody _ such IS helping B cell. produce Ig.'d.
IgOl , IgA and19B,attractionof eosinophils andinhibition of macrophages(Druet et aI., 1996).
1b2 respoasesare often implicated in protectionapinst metazoan parasites, successfuJ
pregnancy. vernal conjunctMtis,1I0pic andaUergic disorders, chronic GVHD (graft versus host
diseue). syslemic sclerosis andprogression10 AIDS in HI\' infcaion (Romagnani. 1997).
Th1 andTb2 cellsare believed to developfrom the samematurenaiveCD4+T cell, often
describedas ThO(ConstantandBottomly, 1997). Initiationofei1herTbl or 1b2 responseslikely
dependson the cdJu1ar enviromnemIt the timeofamigen stinIJlIlion.Thepresence oCfi.. 12,
produced by ldMled maaopbagcs and dendritic ecIIs,induoesI 1b I response l!vough initWion
of the transcriptionfactor5tat-4. Knocking out fi..12 (Magram et aI., 1996)or 5tat-4
(Thierl"e1der et 11., 1996, Kaplan et 11., 1996) rcsulu in multcdly reduced1b I respoeses. lFN-y
also basan inducingeffecton Tbl ceUs,partlyby enhatJciDg IL--12 secredcnby maaopbages
(Thindlieri et aI.1995) and panIyby mainuining fimctionof n. ·12 receptors 00 0>4+ T cdI.s
(GuIer et a1,1996). Tb2 responsesare inducedthrough DA, producedby basopbils, mast cells
andT cells(Thomson,1994)signaledthroughthe transcriptionfactor Stat~ (Heu et aI., 1994)
Similarly'0 lL-12, knockingout IL-4 (Kuhn et aI., 1991, Kopf" aI., 1993) and SOI,-6 (I<oplm"
11., 1996, Takeda" 11., 1996, Sbimodaet aI., 1996) rcsoIuindeficieotTh2.!"'PO"'C'
Previous studies havefoundthatonlyeytolcine secretionandsubscquc:n1 immune
responsescoulddifferentiate betweenTh1 andTb2 cens. Recently, however, several studieshave
implicated several chemokincreceptors u possiblemukers for Thl and Th2 cells . The chernok:ine
r«oplorsCCRS (Zingoniet al., 1998) and CCR' (1loneccIU et aI., 1998) an:differentially
expressed OD aaivaJ:edTh2cells,whileCCR.S andCXCRJare differartiaUy apre:ssed on Thl
ce11s (Boneechiet &1., 1998, Sivekeet &1., 1998). These studieshaveopenedup a largearea of
researdl in thisfidd, sirlceDOW Th1 andTb2 tells CIft becbaraaeriud It the singlecelllevel
basedon surfacemarkers,insteadof ddiniog a population of cellsbasedthe cylolrinesseemed
iDloal1turesupernatant.
2.1.1 n uU crossnplatioa
ODeof the most studied aspects ofT helper subsetsis the fact that Thl and Th2 ceUsare
crossreguiuory. TbeC)'lokiDcs produced by the Thl subset havethe ability to down regWaiea
Th2 responseandvicevena (reviewed in Cor1SW1t andBottomJy, 1997). This finding hashada
great impact in studies of immmoreguJation and ill areasof research where I Th1or Th2 type of
response is unfavorable to the host, suchas orpn-spccific autoimmunity (Tb I) or allergy(Th2)
Tb14ypeC)1okines respoDsible for thedownregulationof Tb2-type responsesinclude
IFN-yand JL.12. IFN-y uw"bits the proliferation oCTh2clones <Gajew>lO et aI., 1988) whilen.-
12 can be usedto reversean established Th2 response(Romaniet 11., 1997). The abilityof n. -12
to reversean established Th2 responsewu demonstrated in experirnentaI ~shmaniasis (Nabon ct
11., 1995). n.-12 was used in conjunction with.Iei shmaniacidal drug duringlate phase infection,
andwu shown 10 switchthe dominant Tb2 mpoose to a Tb1 response,resultingin bca1ing and
resistance to reinfection with L major .
Cytokinesproducedby Tb2 cellsknown to intu"bit Tb1 ceUs andpromotelh2deYd_ indudc 1L-4, ll.-IOIIId ll.-13 (RomagnIni. 1991). lbl celJsgrown ...:u1_
withoutexogenous e:ytokines., sueh. as eeDs spcc:i6e forpurifiedproteinderivative(PPD), can
becomeTh2·likcin cultureby the addition of n. -4 earlyin bulkculture(parronchiet aI., 1992).
T ceIJs fromhoststJw are info<led withL major, poWiud 10 thelbl populltio. bave been
modi5edto produeeTh2 C)1okines by reculturein wtro with n.-4 , fi...2 and APe (Moeci and
Coffman.1995). fi...IOhas similareffects,suppressinglb1cellswhiledecnasing n.-2 andIFN-y
production(Yo... et al., 1991, Top et 01., 1992).
Oneof the most imerestingdebatesof thelb lfTh2 paradigmis whether1111 or Th2
cytokiDe seeretingecIlsan aetuaDy ' switch' to producetheopposing subsetcytokines.TheIcveI
ofeommitmcnt for cytosine production at the singlecell levelis unclear(Kong andLewis, 1990).
It isalsounclear wbetberduringa ' switch' from lbl to Tb2 or viceversa in bulkc:uhures, the
cytolcines presentin thecnvironmem IClU&IJy causea swrteb in the e:ytokine profileof individual
cells,or alloweontaminating eeUs of the opposite phenotypeto proliferate. or act on uneommined
ThOtells in the cultureandallowthemto proliferate. Murphy ct aI. (1996) foundthat fbi clones
andeeJls thatW'CrCc:uJtured underchronie Tb1polarizins eooditions resisteda S'Nitcb to 1b2, and
a reductionofthc IFN-y producing cellswasobserved. Also,Th2 ccUs are often resistant to
phenotypereversal,possiblydue 10 a loss of responsiveness to 0..-12(Szabo ct aI., 1995).
Tbcrcare sevmJ other faetorstIw:affectthebalance betweenThl andTb2 responses
Antigendose in1Juenc:c:s the T c:cU responseandgeneraIty,low doses favor tbl responses, whiJe
higherdoses favor Th2 (Bretschcret aI., 1992, Hoskenet el., 1995). Co-stimulatory signalsin T
edl aetivatiooalso playa role. In somesystemsthe type ofB7 moleculethatbindsto C0 28 has
10
an effect.with B7·1 inducingThl development and 8 7-2 favoringTh2 (Xuchroo et aI., 1995).
Othersrudics indicate that highlevelsof eostimulation in gencnl £avor• Th2 response
(DiMolfettoet aI., 1998). Lowerc:ostimu1ation mayrauh in Tbl responsebecauseTh ! cdls may
be less dependent on the levelofT cell activationas they get theirstimulatory cytokinell.·t 2
&omAPe (Murphyet 11.,1994) . Some otherfacton mcJucle the genetic baclcg10und of the
animal., as demonstratedby L major studieswhere susceptibilityto L. major wasdependanton
the strainof mouse., aod the route of antigeuadministratioll.
1.2 Thlll'h2 cdb ia autoimmuairy
2.1.1 Overviewof tbe role of Thl cdls ia OrplHpcdrlC autoimmu.ity
Many organ-spec:ific autoimmunediseases., such as Wulin-dependentdiabetes mellitus
(IDD M). multiplesdetOsis(MS) and ItT an: mediatodbyTbI ceD.(Ublau et 11.,1995). The
cress regulation of theT helpersubsets hasfocused on the POSSlbility of deviating the T cell
response in thesediseases from I ' pathogenic' Tb l response to. ' protective' Th2 response in the
animalmodels for MS and 100M (Liblau ClaI., 1995, O'Garra et aI., 1997. Druet et aI_. 1996).
E.xperlmenJal ...hd otmmunre EncqJhaJomytlitis (EAE):
Experimentalautoimmune encephalomyelitis (EAE) is a model of certainaspects or MS in
taunans. It is inducedin rodents by injectionof mydinantigens suchas myelinbasicprotein
(MBP). proteolipid protein (pLP) andmyelinoligodendrocyte protein(MOO) in CFA (reviewed
11
in O'Gam d at. 1997). Thepathogenesis ofEAE involvesCD4+T ceUs but not CDS+T cells
T'bere are~ linesof evidence that indicatethat TbI cellsare iDvoIvcd in the indUdionof
EAE (reviewedby Drud et aI., 1996, Ltblauel al., 1995). FntIy, the intJammatory response in
thecentral nervoussystcm(CNS) resembles. om reaction.which is known to be Tal-
mediated. Tberc: is • strong correlationbetweenDTHresponses to myelinantigens and the
development ofEAE . Immunohistochemical studieshaverevealed the presence orTbl eytokines,
fL.2, TNF-ll on<! IFN-y in CNS tissues II the heigblof diseases,on<! the abscuoc ofTb2 cytokines
such as n....-4. EAE CID be transf"errcd passivelyinto naivebostsby TbI ceil clones specific:: for
onc:cphalit<>gali< pcptides,derived from enc:cphalit08aU< lesioos. but not by Tb2 <ellclones
(Baron dol.• 1993).
/1UJI/in lkf¥ndem D;abetn M,llitllS (lDDM) :
In thecaseof IDDM, studies in theB8 rat andNOD mouseindicate that IDOMisT-«U
mcdWcd (O'Gam. et aI., 1997). There is evidencethatbothCD4+ andCDS+-T cells are
involved in the pathogenesis oCIDOM,throughstudiesusing depletingantibodies againsteither
subset(Kikutani d II., 1992). Howewr. thereareother studies that show CD4+ T cellsalone
caninduceIDOM (Katz et al., 1995). III the IDOM modeithe specificpathogenicAg Us not
boondetmnincd, yet th.lkeUproteingIutanU• .ad d_ xyluc (GAD) ....... likely
candi<iate(Druct et al., 1996 ). The idea that mD M is. Tbt-mediateddisease: is supponcd by the
observation that T cdls fromNOD miceprodu.celargeamountsofIFN.'Y in responseto GAD
(Kaufinan d el., 1993, T tseb el al., 1993). Also. theincreased expression of IFN- y under the
controloftbe rat insulinpromoter(RIP ) resulted ill inflammation of islets anddiabetesin
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tnnsgenic:mice(Sarventni ct CIaI., 1990. Stewart d aI., 199) . Both IFN-y (Campbell CIaI.•
1991) andD..-J2(Tranbleau et at . 1995)havebeenshown to promote IDOMin mousemodels.
1Jladdition, as in theEAE model.T cellclones specific: for GAD. thathadthe ability to accelerate
mOM in NOD mice. produoc:d fb i type cytokinesafterrestirrKllationin vitro (Bergman e aI.•
1994).
1.1.2 nl to Th2 immuDe dniltio. i.luloimmg.ify
Manystudies have focusedon switchingthe 'proinflammatory' Tb1 response in organ-
specific: autoimmunity to. ' protective' Th2 response (reviewed in O'Gam et aI., 1997) .
However, the effectivenessofTh2 cdJs in havinga pro tective and/or therapeu tic effectmorgan-
specificautoimmunityhasyet to bedefinitively shown. In somecases suchu in
imrnuoocomprimi hosts. lb2 cellshavebeen shown to bepathogenic in theirownright
(Lafaillee..I., 1997, PabIa et ~ .• 1991).
In the EAE model.the first anempts to ameliorate thedisease were made using
monoclonalantibodies to theproin1lammatory C)1okines Lt2 md IFN-y. Administration of a
amibodiesto L 12 in micefollowingadoptivetrans1'er ofPLP-primedLNC (Leonard et aI.,
1995)or immunization with PLP in CFA(Gijbcls ClaI., 1997) inhibited thedevelopment of EAE.
In COntt'Ut, the use ofIFN-y specific: mAbshadDOefl'ec;t on EAE (Doung et aI., 1992) or was
shownto enhmte its development(Billiau et aI., 1988). OtherSlUCfies in hunw\sindicated that
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treatment with lFN.y eu<erl>alcdMS 'l""ptoms (panitch"II., 1987).
The usc ofTh2 cytokines to skew the inftammatoryresponsehasalsobeen stUdied in this
modd . In EAE. u in thehuman condition. thereare oftenstages ofrdapse and remission, and
during the stage ofreccvery, IFN-y RNA andprotein levels are low whileIL-4, IL-10 and TGF-~
levds an: high, imp!iatinS' Tb2 response withroc:ovuy(K!lowy" II., 1992, Kennedyet II.,
1992 ). In the EAE model. adminisuaioo ofD..-4.IL-IOand ll..-13 hushown benefiWJ effects on
the progress of the disease(RIcke C1aI.• 1994, Ron et aI., 1994. Cashet aI., 1994). Yet there
havebeen somedisctepanciesbetween these findingsandthe studies of others. panty because of
differencesin animalmodelsandtimeof cytokine introduetioa.. For example. early treatment with
fi....4 amelioratesEAE in an adoptivetransfermodel(Racke CI aI., 1994), yet n..-4 administration
at the time of diseaseinductionor onset exacerbatedEAE (Gijbels et aI., 1997). In the same
study, the we orIL· IOIwllittle elf"". Enc:ephalitos"'"' T eeuh}bridonw uansduccd with .
retrcviral geneto expressfi....4 delay the onseI: ofEA£:whenadoptivelytransferredintomice
immunized withMBP(Shaw et aI., 1997), andsimilariyPLP-specific memory cellstransduced
with IL-I OeDNA werealso shownto inhabit EAE (Mathisen et al., 1997). Finally, the use of
PLP-derMd altered peptide ligands (APL) which _ Tb2 ccU, ronfencd protet:tion from
EAE inducedby the administration of PLP in CFA whenadoptivelytransferred into mice
(Nicholson et al., 1995).
In odditioo to the above stu<fi... Khoruts.. II. (1995) found IIw PLP (139-151)-spcci1i<:
Tb2 cells<OUkt IlOl suppressEAE induced by TbI ccUs LaWll." II. (1997) foundIIw in
immunodeficienthosts., Jh2 cellsClWsed • fonn of EAE with allergy-likepathology. The above
datasuggest that the idea that ThI ceUs are pathogenicand Tb2 cellsare protective may be too
I '
simplisticIDddw theremay besome othertype of regulatorymedwtism roming into play than
the Th ltrb2 balance .
[DVM,
In the mD M modd.,antibodies to n...12RandIFN-y have hadbeneficial effects on the
disease (Liblau et aI., 1995). Also. administrationofII....4preventsdiabetes in NOD femalemice
(Ilapopon tt aI., 1993). AdminiSlBlion oeLIO amdiom:cs disease in NOD mice (pennline et
aI., 1994) yet mousepc;db with0..-10 expressedby. transgcneare destroyed more rapidly
(Wogcnscnet aI., 1994). This destruction may be due to .Iocalizcd highconcentration of the
cytokine . Rccemliodinp in this modd havebeeDsimilarto dati obtained in the EAE modd . in
that Th2 cells themselves arecapable ofinduc:ing diabetesin immunocompromiscd NOD-scid
mice(pakalaet aI., 1997). Theseresults also suggestthat another type of regulatory T cell, such
as T regulat ory edI 1 (1 rI) or Th3 may be important in thedevdopment of IUtoimmune diseases
(pabla . u l., 1997).
Novel approaches to the study aCtbe ThlfIb2 baJance in autoimmunestates include
modelssuch as H.- tOand IL-4 uansgc:roc anddeficientmice(Bettdli et aI., 1998), TcR
antagonists (Anderton et aI., 1998), genetic imrmmization \Vimeytolrinegenes (Ramshaw et aI.•
1997) andthe usc of androgens to affect the ThlfI'h2 shift. The resultsin theseexperiments
suppon the ideathat other !Klan besides the ThlfI'h2 b&lance. such as regulatory T cells, are
involvedin organ-speeificIUloimmWlity, and thaianypotentialimmuno~py must take these
factorsinto account.
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2.2.3 Tb uIII ia EAT
The role of'Ihl andTb2 ce1ls in inununorcguJation orEAT has not been as well
tban.cterized. EATinducedby immuniutionofmiee with Tg in CFA.is consideredto be
mediated by CD4+ T cells(Kong et aI., 1990) andthesecellsare believedto beoftbe Tbl type
(Druet et aI., 1996).11basalsobeenshown that the CD4+T ce1ls infi1tn.ting thethyroids of
patientswithHT are oCtheThl rype (Miossec.1997). Thishas not beendefinitively shownin the
mousemodel. although,as described below, much irJdirect evidenceindicatesthat they are Thl .
n.-12 hasbeen shownto exacerbate thegranuJomatous formof EAT. resulting in an
extremdy severe anddesuuaive formorEAT in recipieatmice(Braley-Mullenet aI., 1998).
IntrathyroidalinjectionofIFN -yalonebasabo beenableto induceEAT(Remyet al., 1987)
MAbsto IFN-y during the developmentorEAT significantly attenuatedthe disease in mice(Tang
et aI., 1993). Usingmice that were deficientin the IF'N.y receptorgene, AIimiet al. (1998) found
thai although IFN-ywas oot requiredfor the inductionof EAT. it was requiredfor progressionto
tunblowndisease . Contradicting thisfinding,injectioaofmAbs to IFN-yinto miceimmunized
with19 hasresultedin an~led formof gnnuIonwous EAT in naivehosts,whith is
inducedusingrnTg-aaivatcdspleenceIlso(the immunized miceculturedin the presenceoranti-
D..-2-R(Tang et aI.• 1998). lmrnunizationof IFN-y- deficient mice with 18 hasalso resulted in
thiscucerb&led.formofgnnulonwous EAT in thenaivehosts(Stull et al., 1992). Theabove
dataseemto comradia: the assumed roleofTbl eeusIS initiators orEAT.
The use ofTb2 C)1okines n....andfL.10 has also yielded interesting resultsin EAT
studies. Mignon-Godefroy et aJ. (1995) studied the effea of in vivo administrationof recombinant
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bumaD IL-IO(rftlL.IO)on the developmentof EATfoDowingdirect immunization with mTg in
CFA or adoptivetransferof mTs-specific: T cells into naivehosts. They found that administration
ofrfill.. IOwas~ c:f6cicnt in both preventing and treatingEAT. They contributed this finding
in pan to rhll..-IO's enhancement of T-cell dwh. In the ' transfer EAT' model, spleen cells from
CBA/1doDOrs previouslyprimedin vivowith mr g wereeulturcd with or without rII..4 or rn. ·I O.
L IOwasshown to decrease mTg. speci6e proliferativeand cytotoxic T cdl responses. while n.,.
4 hadlittleeffea (MignoJKJodefroy et at, I99S). Anothergroup. de la Vega er aI. (1998) found
that L IDmRNA expression in human th)TOid can beincreased in thyroid autoimmunity but only
in uses of severeinfiltration. Thepresenceof a lb l· inhibiting c:ytolcinein lesions that containT
cellsof the Thl cytokinc profilewasnot explained. In contrastto this finding.the application of a
plasmid containingIL-IOonto the thyroid. in lIiwJ had . curative drec:l on EAT (Baneux Clal.,
1999). Theuseof the plasmidwasshown to inducefastandlong lastingexpressionor n.·ID in
mouseTFC. It resulted in• loweringof the mononuclear cellinfiIuationof thyroidglands anda
diminishedanti-1 8 T cellprolifention. It alsoinduced• trend toward the Th2 response. indicated
by. decreased productionofIFN..y andincrease in theratio oflgGllIgG2a. In the
gmwlonwous EAT modd, theaddition ofrll..-4 ill \IItro to o.1Itures ofspleen cellsfromdonor
mice immunized with 18 badlittJe to no effecton thedcvdopment or EAl in the naiverecipient
mice(Tang et aI., 1998) .
Theseresulu indicate that for EAT. the most powerfulThl· inhibfting factor is n..•O, Vrr'ith
Q...4 playingljttle rolein decreasing theseverityofEAl. Theyalsoshowthat novel tedmiqu es.
such as thewe of plumids encoding cytokines to induc:e cytokiDeexpression by TFC (Baneux et:
aI.• 19(9). may be SU«eSSfu1 in both the prevention and Ueatmenl of thyroid autoimmunity lo the
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3. T CELL DETERMINANTS IN EAT
3.1 DJ1"'OCIobulilllS .. alltizm
Thyroglobulinis • large, highly conservedglycoprotein with I homodimeric: molecular
weight of approximately 660kDa. It is tmISCribcd fromI gene foundon chromosome 8 in
lIJm&ns andon chromosome IS in mice. TI is syntbesiudin theendoplasmic: reticulumof
tbyrocytel, modifiedpost-transWionaDy in the Golgi,andthen seemedinto the follicular lumen
(Van Hcrle et a1.• 1979 andEkholm andBjorlanan, 1990). It is expressedonly in the thyroid
gland,whereit is the mainconstituentofthc c:oUoid oftbc tb)Toidfollicles (Caturegiiet aI.•
1997). llSmaUl function~ in the synthesis of lhyro;dhormones, through iodination of n. tyrOSine$
(Caturegliet al.• 1997)10formT. (thyroxine)andT1 (triiodothyronine), yet it has been recently
shown to possess TGF-tl activi ty (Huang eeaJ.• 1998).
Tg hasbeenthe majo<...cantigenDnptiat cd in the pathogenesis of EAT. In 1fT. bolhTg
andTPO are believedto be major IUCoantigens. In 1956, Roitt et 11. showedthat patients with
fIT developed Tg-specific antibodieswhileRose and Witebslcy (1956) found that immunization of
rabbitswith Tg in CFA result ed in thyroidinfiltration. Since that time. nwnerow: sud ieshave
confirmedthe pathogenic role ofT g in autoimmune: tb)Toid disease, andTg-specificT cells in
both the induction andeffector phasesorEAT (reviewedby Kong, 1994).
T8 is also a highlyconservedmolecule. 'Three species of Tg have beencloned and fully
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"'lUenced It theeDNA 1M. TheseIn: humanTg (hTg) (MaItlliay ClI1., 1937), bovine Tg
(hTg) (MerkCllClI1., 1985) andreccntIymou.. Tg (mTg) (CaturegliClI1., 1997). The C·
terminus oCm thyroglobulin(r1g) hasalsobeen sequenced(DiLauroeeaI., 1985). Amongthese
spec:ies thereis • >70% identity in theLa. sequencewith ,lUgh degree of conservative
substitutions(Can.yanniotis and Rao. 1997, Caturegli et aI., 1997). Thishighdegree oChomology
iDdic:ates thaIpathogenicepitopes of 18 mayalsobe highlyeoeservedacross species. Tg also has
• highdegree oftmemal bomology(MaItlliay eeaI., 1987, Merken ct aI., 1985) wheremore than
75'1, aCthe sequenceis composedof3 typeS. or domainsof repetitive sequences(Canyanniotis
andbo. 1997). Thesedomainsare; DomainA with 10 tyrosine-andcysteiJle.richrepeatsof SO
La. between positions29-1196. DomainB whichbasJ repeats of 14-17 highlycooserved
residues between position 1436-1483, DomainC with S repeatS betweenposition 1583·2109. The
last Domain(0) lacks intema1 homologyand is at the C-tc:nnina1 endof themolecule.
Thereare 11leasttwo featuresof 18 synthesis that may affeclgc:nention ofits
path~c epitopes. FtrSlly, 19 is not. sequesteredantigen,but it is continuously releasedinto
thecirculation,along withI s andT. (CarayanniorisandRao, 1997). It wasbelieved to bea
sequesteredantigenuntil thedevelopmentof sensitive tedmique$ to mea.sure Tg in circulation
(Sdmcidcr andIkekubo. 1979). It has DOtbeen determinediftlUs released18 is intactor rdcased
in smallerfragments. Processingof Tg fragmentsby APe in "'\10 maydifferfrom the processing
ofintact 18 in IIItro , resulting in the generatioa of pathogeniccpitopc:s. Secondly, iodinationof
T8 may influenceits patbogalicity. TheTg molecule, consistingof two identicalsubunits.ismore
stablewhen iodinated(Champion et &1., 1987). Champion et &1. (1987) also foundthat poorly
iodinatedT8 failedto dicit EAT in mice, indicating thatdominantpathogenicepitcpes may be
19
iodinated. Also, epidemiological evidencesuggeststhat geographical areas of high iodine
eotrdatc with the incidenceof thyroid IUtoimnwnity (BouJcis et al, 1983, SzaboIcset aI., 1997).
3.2 Epitope MlppiaJ ortb~Tbyroglobalia molKu~
3.2.1 Mlppcd tlI)TOIIobulia epitopa
Identificationof pathogenicT cell epitopesofTg isvital to study of thyroiditis. It is also
erucial to thedevelopmentofpocentiaJ strItegies for immune therapy. Due to the molecularsize
afTs. epitopemappingtechniquesbasedon overlappingpeptidesare both impracticalandcostly.
nw.. othermeansof findingepitopes IWSt beemployed. takinginto IICCOWlt CUrrent kDowlcdge
of bow peptides;"'end withT <dis. TheseothermethodsincludealgorithmstIw predict
pcptidesthatmaybindto MHCmolecules,andthusare candidatesfor T cell .eti ....tion. Others
includestudyingthehomology ofTg withotherthyroidal antigens suchas TPO. the exploration
ofpept.idcs containingthe bormonogcnic: sites cfTg, andthe use of hybridomas derived from
lhyroid Jcsions.
To date, there are five mapped T cell epitopes in T8. Thelargest oftbese is. 40 a.a
peptide [Tg(1672-171 I)], discoveredby Texieret al.(l992). Thisgroupused a cytotoxicT un
bybridoma (KIO), as a mappingtool. HTC2 hadthe abilityto lyse in vitro, macrophagcs pulsed
with eitherintaa porcine tbyrogIobulin (pTg) or a smalltrypsinfragment afpTg . They alsofound
that the smaller fngmcnt oepTg hadthe ability to induceEATin H-2' strainmice. Pre-
immunization of thesemicewithHTC2conferredprotectionfromEAT. This indicatedthat the
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peptide fngmentwas indeed pal!log";c . They purified and sequencedthe pTg-peptid. fngmenl
and fowldthat it bad70% bomoIogy with the knownbTg eDNAsequence. As the sequenceof
pTg wasunknown,they syrrtbesiud. peptide fromthehuman T8 sequencehomologous to tJUs
region. They immuniz.ed mice with hTg(1672.1711)anddiscoveredthat EAT was induced They
alsofound thatautomtibodies in the sen of theseeeee weredireaed only to the peptide,
bTg(1672-I7I I) and DOl intactbTg
The rest of the fourmappedT ceOepitopesclusterat theC-terminal endof thyroglobulin,
• eysteme..poorregion homologousto acetylcholinesterase and other esterases (MaltJUery and
Lissitzky. 1987, Takagi et aI., 1991). Rom and colleaguesstudied a sequencecontaining.
thyroxinesite u. possiblepathogeniccpitope. In humans. T) andT. residuesmaybe fanned
fromtyrosines at positionsS. 2553, 2567, and 2746(Hutchingset aI, 1992). They believed that
iodinationat these positions mayaffea~. Previous studies by thisgroup indicated
that two murineTg autoreac:tivc bybridomasrecognizedan epitcpe containing T. acposition
2553. The peptideepitopeTg(2549a2S60) lostits immunogcnicity if the T. at position2553was
substitutedwith any other I .a. Thepathogenicpotentialof this peptide wastested in COAlJ(Ii-
2') miceand it wasfound that thispeptide _ EATby adoptM cnnsf" but DOl by dUect
cballeage intorecipient mice. Thispeptidealsoinduced T.eellproliferative responses and
antibodyresponsesin miceimmunized \IrIith 18(2549.2560).
Hoshiob et aI. ( 1993) investigatedthe two kno9rr'n thyroid antigens. Tg andTPO andthey
sc:arched(or commonsequencesthat may aa u T-epitopes. They scanned the human Tg and
TPO sequences andf~ fourS a.L residuesequences that werecommonin both. They then
tested the Tg aDdTPO pcptidcs containingthese identical residues for their immunogenicity in
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mice. Tbeyfound thatTS<273~274])was antigenic.as wa its TPO coumClpUt. TPO(I1S.131)
(Hoshioka e aI., 1993) iDthat they irxfl.ad EAT in mice.yet only through an indirectmelhod.
They found thatwhensplenocyte!frommiceimmunized with mTSwere stimulated in vitro with
these pqmdcs.as weDas with mTg, they tnmferred thyroiditisinto naiverecipients. The faa WI
thyroiditisc:ould not bedircafy inducedin animals challengedwith this peptide in Cf A was•
majordnvro.ek of thisstudy.
Carayanniotis andcoDeagueshave mapped two pathogenic T cell epitopes at the C-
terminalendafTS· The tim, r1g(24 95-2511). designated TgPl. wasfound using lhecomputer
algorittuns •AMPHI' and ' teeaee- motif '(Chronopoulouand Carayanniotis, t992). This t r-mer
peptide wtlich__ in !be lIvyoids of EATsusceptible suainsof mice(SJUJ, em
&tidBIO.BR)but not EAT resistant arains(BALBIc and BI O). It waslater found that this peptide
alsoind~ EAT in rats (Balasaet 11., 1993). TgPl WIS identifiedas non-immunodomiJwlt, as
TgPl-primedT cells didDOtresponseto intactmTgor tTSin wU'O and. convcne/y, mTS- and
rTg- primedT cellsfailed to respondto TgPl. Serologically, hTg-primedmiceshowed strong
mTg-specific JgG response butno responseto TgPl. However, 19Pt-primedmicewereshown
to elicit strong IgG responsesto TgP l that aoss react withmTg, rTg, bTg. bTg andpTg,
indicating • strongly immunogenic:peptide. Thisgroupbassince delineateda 9-mcr peptideof
TgPl , (2496-2504) IS.minimalpathogenicepitopeofTg (Rao et aI., 1994) ,
Anotherpeptide.rTg(269S-2713) wasalso foundusingthe sametompUter algorithms.
andwasdesigrwed as TgP2. This peptidehada unique genetic patternof ~u<:tion of EAT. It
caused EAT in SJlJJ mice(H.2") micebut not inH_2l mice(C3H, B10.DR), whichare typically
' good responders' to EAT (Canyanniotis et ai, 1994)_EAT in SJlJ) micewas inducedboth
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dinctJyandvia adoptivetransfer, andthe T eeDs of these miceproliferated ;n vitro to TgP2. All
strains testedexJubited TgP2. specificIsO (Can.yanniotis et aI., 1994) .
Ofthe fiw T edl epitopestNt have beendisco....cl, nonehasbeen shownto be
immunodominant. 'Ibis is not particularlysurprisingconsidering the sizeof the T8 molecule.
However, recent devdopmcnu En the field. sueh IS thedetermination of the sequence for mTs
(Caturegliet al., 1991)andthe aystaJ SU'\IClUTe of themouse A' molecule (Fremontct 11., 1998)
may lead to thediscoveryof otherT cell epitopes. Due to the high homology across many
speciesof Ts. thesenewepitopesermT g VriIllike/ybe shared aaoss otherspeciesof Tg.
3.1.2 n eUK .ralcorithms 18 epitope mappiDC
Vladutiuand Rose (1971) cliseovered that miceo(H ·2' or H·2"haplotypeSare 'good
respond",', highly sus, . ptibleto Tg-induced EAT. Miceof theH-2' andH.2' haplotype ee
d&ssi.fied as 'poor responders''With lowerT ceDresponsesandIirtlethyroidtnfiltntio n (Vladutiu
andRose, 1971). Susceptibility to 19·inducedEAT iJcomroUed by genes in the H·2A
subr<gK>ns, while the H2-D andH-2K subregions ha", _ control (Beisel and Rose, 1983).
For thisreason. algorithmsscreening the T8 sequencefor the existenceofpeptidcs bindingto H·
2A and H·2E in susceptible H·rmice are usedto map pathogenicT cell epitopes (A1tuvia et a1.,
1994).
Thereare other methods used to predict T ceUepitcpes. Antigen-specific T cell
hybridomasdaived frominflammatory lesions havebeenusedto predict T cellepitopesof myosin
in myocarditis(Donenneyer el al., 1995)andTS in thyroiditis (Texier et al., 1992). For smaller
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antigens,such asmyelinproteolipidprotein (p1.P). anantigen implicau:d in the pathogenesis of
EAE, overlappingpeptidescoveringthe wholemoleculewere tested fOrtheir ability to bind to A
moIccu1es, anduItimaIdycause EAE(GRor" 01., 1996). Thisoverlapping-peptideteehnique
wouldbeverycostlyandtime consuming ifperfonned on the Tg molecule.
Early algorithmswere developedempiriea1ty and were basedon commonfeaturesfrom
peptidcsbindingto A or E molecules. A brcaJcthrough in thisarea c;ame from ADen et a l., 1987,
who firstdemonstratedthat certainfeatures ofa peptide assoc;:iated with the A' molecule(in this
case HEL(S2-61) a dominantepitopefromheneggIyzozymc) were responsible for it!
imrmmogemcity. They were able to show througha.a substitution analysis that within a peptide.
certainI .a. residues make contact with the A' moleculeandothers make contact withthe TcR.
Thesediscoveries laidthe foundarioafor stUdies that lookedat mWtiple lmmunogenic peptides
andascertainedconunon"I. sequencefeatures sharedby aDpeptidcsthat boundto the A~. They
established that the presenceor absenceof certIin "I. 11 givenpositionswithin I peptidebasI
directimpacton its immunogcnicity. Thestudy of many peptides that bindto moleculessuchas
Ak and the common featuresofthcse peptidcshaveresultedin the formationof algorithms
Both A' andF moleculeshavebeen studied cxtensi\'Cly andseveralalgorithmspublished,
estimatingpcptides that shouldbind to it (reviewed in Nelson et aI., 1996). AlTuvia et al. (1994)
developed• computerizedmethod for recognition of peptidcsbinding to A' or E' usinga cobon
of pc:ptidesthai were mown to bindto tbc:semoleculesandelicit I T ccD response. As a control
they used another cohortofpep tides that failedto bindto A' or E~. Motifswere constru cted that
consistedof both pbysical-cherrUcal andstrudUn1properties oftbe aminoacids thatcould occupy
a partiQ.llar position in the prospectivepeptide(AlnMa et aI., 1994). These motifsspecifya.a at
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certainpositions IS critical for thebindingofpeptidc 10 MMe.A study by Kelneret aI., 1992
supported.the idea that A' andE'-bindingpeptides havecritieaJ anchor residues. Thestudy
demonstraled that . single La. substitution in theAk-rcstriaed peptide Mt eyt (93-1 04) (mouse
testicularcytochrome c) at position 96 from a.a. lysineto alanine changed the restriction of the
peptideto E'. 'Ibis iDdicated that this L a. wu mmebow altic:&J for the isotype spec:ilicity. Several
other studies(Nelsonet aI., 1996andItohet aI., 1996) havealsodemonstrated that certainLa
are essential for I peptide to bindto the A' molec:uJe
An A'-peptide bindingmotiflw~ beenpublished. stemming from thediscovery of
the aystaJstructure of Ak in complex with thedominant epitopeHEL(S0-62) (Fremontet aI.,
1998 ). Thisdiscovery gives. visualrepresentation anda stJUawal basisfor an accun.te Ak
peptide-binding motif. Thecrystalresolutionindicatedthat I peptidebinds to the A' molecule by
the 'burial' of 5 . ... sidechainsinto pockets in the A groove. TbcsepocketSare foundat position
1.4, 6, , and 9 (Freemontet aI., 1998). Ofa11 thesepockets, PI edUbits the most exclusive
binding,with theLa aspartic acid • nearperfectfit . Position P6basthe next mostexclusive fit,
acceptins tither glutamine or glutamicacid. Position 9 typically ac.cepts small residues such as
serine, but will accepc: largerresiduessuch IS threonine. Positions4 and 7 will accepta larger
numberof substitutions,yet for P4mediwn-sizehy(ltophobic: residuesarepreferred andP7 can
acceptany amino acids except those witha positive charge. In addition. the crystal structure also
lrnp6QtessevenJpositionsas possible TcR contld residues, dueto theirhigh exposure to
solvent. Theseoccurat positions3, S, 8 andI I. This study confirmsmmy of the assumptions of
previousmotifsandit providesclear rulestha t di<:we peptide--binding10 A ~.
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Female Sllll. 011. COM. AKR. md mal. Sllll .... were purclw<dfromtheJackson
Laboratories,Bar Rubor , ME, USA.Thefemalemicewere usedfor immunizations between4-
10 wceIcs of age. ThemaleSJlll.. micewereusedfor extractionof thyroid,spleen andlivertissue
onlyandwere\lSCId at 2()"2Sweeksof age.
2.2 ANTIGENS
peptidesdesignatedTgPl [rTg(249S.2SI I)J md TgP2 [rTg(2695-2713))weresynthesized II
>95% purity at the AlbertaPeptideInstitute(Calgary, Alberta.Canada).Theyweresynthesized
Oft an AppliedBtosystCllU (FosterCity, CAl 430A synthesizer using. general procedurefor
soUd-phase synthesisnuilincdbyEriksonmd Merrifield(1976) withmodiJialions by Hodgeset
at (1988). This procedureinvolved hydrogenfluorided cavagc of peptide resinat ·S-C for one
hour in hydrogen flouride:anisole:dimethyt sulfoxide(DMSO): p-thiocresol: peptideresin
(IOmI:l mI:O.SmI:O.2ml:lg). peptidepuritywu ossessed by IlPLC md massspearoscopic anoIy·
sU.
Peptidesof rTg usedto immunize micewere chosenusing overlappingA andB motifs from
27
Altum .. aI. (I994~ u outIin<d in section:U These ..... Ts( 1827-183~ Tg(2()29.2040~
Tg(2108-2125), Tg(2424-2437) ond Tg(2597-2609). These peptidee weresynthesized by Synpep
(Dublin, CA, USA).
:u ALGORJTIIM-BASED SEARCB FOR A'-BINDING PEPTIDES IN TG
'Ibe paper entitled 'SequenceFeaturesthat CorrelatewithMHCRestriction' byAltuviaet II
(1994)desaibed analgorithmforprediction ofpeptides that may bindto A~ or F-molecules.
Fromthis paper.weusedtwo motifsto screenfor peptidesthai:maybindto the A~ molecule
(Table 1.1). The pcGENEsoftwarewas usedto SCIII the961 a.a. on the C·tenninal endof the
rTg moiea1lc(DiLauro et &1., 1985). and later thecompletemTSsequence(Caturegli et &1.,
1997). We initiaDy usedrTg bceause the completesequence for mTghadnot been publishcd
Usingthisprogram.we fOWld sequenceswithinthisportionofrTg that fit motifA andmotifB,
sepanteIy. w. then ebcse peptid.. in whichmotifA and motifB ccmpIetely overIappecIwitllin
the peptidesequence. We then alignedthe ponion aCmerTg sequencewith the knownmTg
molec:ule (without the presence of the leadc:r sequence ) to get the peptideco-ordinatesof our
candidate peptides
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All ....!" wee performed in Du!bcc<o', modifiedEagle(DMEM) medium (Gibco ,
BorIington,Onurio , Canada ) suppl......edwith 10'" fetalbovineserum[(FBS)(BKlprodueufor
Scieoce, lndianapoIis, lN, USAL20mM IlEPES buffer, 2 mM L-GIuwnine, 100 unitslmI
pencicillin, loo ..wmlSUeplomy<in (aDfrom Gibco) IIld S. 10"' M 2-......ptoetbanol
(MEXSigmaCbenUcaIs, SI. Louis,MO, USA).
1.5 ANTIGENIC CHALLENGE OF ANIMALS
1.5.1 b dactioa oraatip_ specificLNC
Micewereinummized with S0-200~ofTgPl orTgP2,or 100nmol of eitherof the six
peptides [Tg(1827·1837), Tg(2029-2040), Tg(2108-212S1 Tg(2424-24l7), or Tg(2S97-2609))
in a 1:1 emulsion mComplete Freunds Adjuvant (CFA)(withMycohot:tm llJJl Intt)riaun. Difco
Labontoriesln<. Detroit, MI, USA) They__ inunwUzcdsubcutaneously (underether
anaesthesia) at 3 sites alongtheback. After9-11days. somemicewereeuthanised with ether and
theirdraining inguinal. auxiliary and brachiallymph nodescollectedaseptically. A singleeeu
suspension wasprepared by passing the Iympb BOde uS5LIe through • sterilestainless seed wire
mesh (Si-. St Louis,MO, USA1 11ldwashedin complete cuItun: mcdUlPMEM + 10'"
FBS)
we werecultured in96 wellplates11 a concentmion of 4 :II:10' celbIwell for4 days in the
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praeooeof titratedamounts of the appropriate IDtigat in 200~ microeultures. Eighteenboun
prior to harvesting.1 IolCi of '[H]-thymidine wasadded to eachculture in 25 IJ,I of culture
medium. Theoellswere harvested18 hourlater. usinga semi-automated~ harvester(Skatro n,
Sterling. VA) andincorporatedthymidine was counted in a liquidseintillationcounter (LS3801;
_lnslJumcnts. PaloMo. CA, USA) StimuIaliooindex~ clefincd IS (CPM in the
presence of antigenICPMin abseDc:e of antigea).
To determineif the peptidcswere thyroiditogenic. somemicewere boosted at 3 weekswith
SO nmoIofpeptide in Incomplete Freund' s Adjuvant (lFA ). After two weeks, these mice were
bloc!, Uldthe resultant .... usedin antibody WSA (see %.602). TheU thyro;d glands were then
removeden bloc with the trachea andfixedin bufferedformalin.The lobes were thendissected
from the tracheaandembeddedin methaaylatc. Approximately40 sectionsat 3.0 J.11n intervals.
wereobuinedlbroughouteadl gland. Theywere fixed'0gla>sslid.. Uld stained with
haematoxylin andeosin. Scoringwaspafonncd asfollows: 0 '"'00 infiltration;l-im mtitial
accumulationof inflammatorycells; 2'" one or more fociof int1&mmatory cells at least the sizeof
one follicle; )-extmsivc infiltration, 10-40% of the loW area. 4- extensiveinfiltration, 40-800/0 of
the total area;, S&CXtensive infiltration, >80".4 of the'toW area. Thehighest infiltration score
observedperglandwasassigned to each mouse .
1.S.2 IDduC1ioa.rnt IDd T1a1cdb
Antigen-primedLNC generated as describedin 2.5.1 werecultured in vitro in two separate
selUP'. Theywereplacedin culnuescontaining either 10' ceIlsIml,10 >'S'm1 peptide Uld 30 og/m1
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rn....4 (Gibc:o), or a culture with 5 x 10' ceUslml,10 ~Wm1 peptideandno exogenousC)'tokines.
Thisfollowedthe protocol outlinedin Khotuts et aI., 1997. Cells were thenc:ulturc:d for4 to 10
days. LNC are resuspended fromcultureandwashed in complete media.1· 5 x 10' eeDs arc put
into 2 ml ofmedia. and3 m1 sterileFicoU-Hypaque (phannaciaBiotechInc., Baied'Urfe.
Quebec. Canada) layeredbeneath it. Thetube wu thenspun in a centrifuge (Beclonan GPR
Centrifuge. Becbnan, PaloAha. CA,USA) &12000 rpmfor 1S minuteswithno brake. TheeeUs
were thenremoved from the medit/F'1COIl inter&ceandwashed in eomplete mediaand counted
using0.02%uypanblue(Gibcc, Burlington, Ontario, Canada). ViableLNCwerecultured at a
c:onccntTation of Irf' cellsfmlandrtStimuIated in thepresence of 10 I!IVmI of peptideand S x 10'
cellsfmI of mitomycinC·treated splenoc::ytes. SpleenswerecoUecled aseptieallyfrom eaivebcalthy
SJUL mice andsingleeellsuspensionswereprepared by passing the spleentissuethroughsterile
stIinIesssteel mesh (Sigma.St. Louis.MO. USA). The resultingcellsuspension waspipened
vigorouslyto obtainan uniformsuspension ofcells. TheccUs were washed 3 timesin complete
medium. adjusted to S x 10' c:elIsimI andincubated It 3rt with 100 IJ8of Mitomycin C (Sigma.
51.Louis.,MO, USA) for 20 minutes. avoidingexposureto light.The cells are then washedthree
timesin complete mediaandused as APe. In addition, viableLNC were alsousedin LNC




1.6.1 CytOkiD~ ELISA for usasm~Dt of cytokina in cdl culturt' IlIptmataat
Theenzyme: linkedimmwIosorbcm assay (ELISA) wasusedfordetection of q10kines as
follows. Disposable po/yWIyI chloride96-_ ELISA plates(Dynalech Ubonlori... CbantiUy.
VA, USA) were coated with purifiedanti-cytokine capturemonoclonal antibodiesat a
concentrationof2 J!&,ml. ThesemAbs were: purifiedrat anti-mouse lL-2 and lL-IO
(PhatMiDgen. Mississauga, Ontario. Canada), andthepurifiedmAbsfrom the supernatantfrom
the celllineMOl70 IDd11811(American Type CuItun:CeDection(ATCC). Rockville.MD.
USA). for IFN-r andn.-4 respectively. Plateswere incubated overnight at 4-c andwuhed with
PBS buffer. Theywerethen blockedovernight with 1%eSA in PBS. After wuhing with PBS
containing Tween-20(pBS.T), standardsof eachcytckiee were added. in addition to the sample
supem.atanlS.to generatea standard curve. using recombinant ll.-2 . ll.·I O(both from
PbarMingea Missi....ga,Onurio. CuwIa), IL-4(1l&D Systems,MinneapoU~ MN. USA). IDd
lfN ·y (Gibec, llurUngton,Omario,CuwIa). Theplates werethen incubaled overn; g!Ill1 ."C.
and washedagain with PBS-T. They were thenincubatedwith biotinylated m anti-mouse anti-n..-
2, ll.-I O, IL-4andIFN-'Y detecting mADs (pharMingen.Mississauga,Ontario, Canada) at O.S
Jl.glml. The plates were inalbat ed at room temperature for 45 minutes..washed 3 timeswith PBS·
T. then streptavidUHIka phospbawe (SigmaChemicals, St. Louis, MO. USA) odded. After a
one-bout U>ad>I1K>n IDdwashing,100'" .fsubsttlle [1 m&,m1 ~phospbale (Sigma
Chemicals.St Louis.. MO, USA) in 10'1, diet.hanolaminc (Fisher Scientific.Napcan. Onwio ,
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Canada)] wasadded. After anbouc incubation at roomtemperature, theplate wasread on a
micrcplolc'- (Molecular DeYk<s. SunnydIIe.CA. USA) at 40S om.
:z.U Aatibody£USA (or UHSIme.t of aatibody ill ~ra
Thepresence of spec;ific serumIgGantibodywasdetermined byELISA. Microwe1ls of
polyvinylchlorideplate(DynateehLaboratories, Chantilly, VA. USA)wen: COaled overmg!ttwrth
10 IJ8ofmTg orthespecific peptide(describedabove) dissolved incarbonate bu.fl'er. pH9.6.
Theplates wue then b&octed ovemisht withPBS+ 0.1%BSA Sen.samples ortheTa-specific:
mAb55MB (. kindgiftof Dr. P. Lymbcri, Hellenic Pasteur Instinnc, Athens.. Greece) u • ccnrrct,
wereaddedto theplatesforonehourat roomtemperature andtheplateswerethenwashedthree
timeswithPBS-To Then thesecond antibody, anaIkaJine..phosphawe conjugated goatanti-
mouseIgG(Sigma., St. Louis. MO. USA) wasadded to eachwell. AfteranhourIt room
_ !he plates wen: againwubed threetimes wrthPBS-T andp-nitrophenylphosplwe
subslme soIutioo (Sign>&, SI. Louis, MO, USA) was added(I mWm! p- ndtophenylphosphale"
10''' cfiethanoiamUle, 100,.JlwdI) andincubated for 30 minutes Absorbanceof !he p-
nitrOphenylalc product wasmeasured at 405 omusinganautomated miaoplatcreader (MolCOJlar
Devices, Suooydale,CA.USA).
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2.7 ANALYSISOF ENDOGENOUSTHYROIDCYTOKINE .. RNALEVELS
1.7.1 RNA ntnttioa
Mi<:e wereeuthanised usingether. thethyroid gland removed ~n bloc still attachedto the
tnchea,and!henthe thyroid lobes teased &omthe _ A piece rouglllysimilarin size10 the
thyroidgland was removed fromthe liverandspleenof the sameanimals. Thetissuewas
homogenized, !henplacedin 0.5 mI ofTRlzoI (Mol«:uJarRosoarch Centre Inc,Cio<innori. OR,
USA) . The tissuewas then separated into(WO phasesusing0.1 mI chloroformandcentrifuged at
4-C at 1200 rpm. TheRNA remains m. theaqueous phase. This phase WIS placed in. freshtube
and precipitated using0.25mlof isopropanol. andagain centrifuged. Theresultant pellet was then
washed with0.5 ml of 75% ethanol andair dried. Thepelletwas thenresuspended in a JJl of
cfiethypyrocart>on.(DEPC) treated _or. Thepurified RNAabsorbance was!henreadin •
spectrophotometer at the00 of26Oand 280nmto determineRNAyieldandpurity.
First strand eDNA synthesisWIS performed using. kit fromPhaJmacj. (Uppsala,Sweden)
Briefly, 1-5 ~g of RNA(made up to I volwnc0£20 JJl withDEPC-treatedwater) was placedin
an Eppendorfrube anddenatured in. Pedcin-ElmerlW thcrmoc:yeIer &I 6S-c for 10 minutes.,then
chilledon ice. The RNA was thenaddedto • pre-mixed solution of 11 JJl Bulk mix, 1 JJl
dithiothreitol solution, I JJl Not 1-d(T)18, aUprovided by the FU'Sl Strand eDNA synthesis kit.
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Theresultant mixturewasthen heated in the thermocyclcr(perkin ElmerDNATbennocycler,
Cetus.,Norwalk, CT. USA)at 37"( for I hour. andterminated by beatingthe tube at 6SoC for 10
minutes. TheeDNAwasstored at -700c.
2.7.3 Amplificatiod by RT~PCR
PeR amplification wascarried out usingreagentsfrom the PROMEGATW PCRkit (Promege
BiologicalResearch Products,Madison,WI, USA). Briefly,1~ of eDNAwasaddedto 2 ~ of
eachof the forwardandreverseprimers, purdw.sed fromUniversity CoreDNAservices,
Univenity of Calgary(Calgary.AIbcru, Canada). 0.4 mM dNTP nUx,4 mM MgCl, . 2.5 unitsof
Taq DNA polymcrue. Theprimersused werefor gIycen1dehyde.3-phosphatc dehydrogenate
(GAPDH)[S' CCATCACCATCTICCAGGAG. 3' TTGAGATGATGCTTTGACAI .
Thyroglobulin [5'CGGGATCCACCATGGGCCCTTTCCACTACTGGGG, 3'
GGTTGTCGATGTCGTTTACTCCTAGGGCl andthe cytolcine, lL-2[5'
AACAGCGCACCCACTICAA 3' TTGAGATGATGCTTTGACAl. lL-4 [5'
TAGTTGCATCCTGCTCTI. 3'CTACGAGTAATCCATIGCI andJFN-y
[S'AACGCTACACACTGCATCT, 3' TGCTCATTGTAATGCTTGGj. The resultant mixture
was then layeredwithSOJJ1 of mineral oil and placedin the thermocycler(perkin ElmerDNA
Thermocycler,Cetus,Norwalk,CT, USA). A 3()..cycle step program(95"Cfor I minute. 56"Cfor
1 minuteand7:zoefor I minute)was precededby. 5 minutedenatuntion stepat 94"Cand was
followedbya 7 minute~ension stepat 7re.
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1.7.4 AaaJrsil .rPCR Produeu
TheamplifiedPCR produets weresubjected to electrophoresi s on . 1.5% agarose gel
containingO.S1l&'m1 ethidiumbromide, in an electrophoresisclwnber for approximately I hour at
lOOv. Thegd wasviewedand pbotographed using. Cbcmilmager 4000 computer system from
AlpbalDDoteeh Corpon tion (San Leandro. CA. USA). andsavedon disk for later quantitation
andanaJym.
1.1 MEASUREMENT OF PEMlDE BINDING TO A' OR E'
Determination of peptide bindingto A' aCE' molecules was achieved using. compet itive
iahib;,;"" &SKy. This ....y usedthe T cellhybridomu, 3,47 (A' -reslrict od, Dai et 01., 1999) and
8F9 (E'-mtri<tod, 0 '; .. 01., 1999) RCOgniDng the peptidesT.(2SSl ) (a kindgift fromDr. Vi
Chi Kong) andTgPl (Rao et aI.• 1994),respeet ively.In I flat-bottom micrcwell plate, 10'
hybridomacellswere incubatedwith . constant amount oftbeir respectiveligand (O.OSI!Wmlof
T~2SS3) and0.04 ,.gImi.fTgPl~ andscriaIdilutions.fthe UlIubit", peptide(lUghest dilution
100 I!W'mI) and 10' TAJ cells as APe . TAJ expressH_2A'IH_2Ak andH-~IH-2E ~ (Allen et aI.,
1985). whichwerea IciDdgiftfromL.H. Glimcherat HarvardMedicalSchool,andwere
couneoustyprovidedby r .Wans &l theUaivenityofToromo. The cellswerecultured in a toW
or2 00 J,d culture mediumperwcD. After14 houn.100 J,LI ofsu pemawu wu collcetcd from each
weU. truslerred to a newplate.andkeptfrozenat ·200c. Therelativen.· 2 contentof the culture
supernatant fromthe~ bindingassay wasdeterminedby thawing the microtitre plates
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ondoddiDa 10' lL-2 depcnclem CTI.L-2[(Gillis.tll., 19n)(ATCC, Rockville, MD, USA)]per
wcIJ. Aller II boun in cuIturc'{IIJthym;dinc (I. CliwclJ)wasodded. The_ were banested 6
hours laterandthelnccrporal:ed radioactivity measured as outlined insection 3.4.2. CTLL-2 tells
were maintained inculture medium supplemented with100ft supernatant fromeoncavalin·A
activated rat spIcnoeytcs IS • sourte ofL2.
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CllAPTER3
A1TEMPTS TO GENERA n: THYROWITOGENIC TID CEllS
SPECD1C FOR THYROGLOBULIN PEPTIDES
3.1 ABSTRACI
Cross regulation cr lbl andlb2 cdls by the cytolcinesof me opposingTh subset hasbeen
usedin imImmotherapy ofTbl-mediated.,orpn.specific diseases. Therole ofTg.peptide.specific
tb2 cellsin murineEATbasyet:to be assessed in vivo. This studyat1emptsto 'switch' Tg-
peptide.specific1111 populations ofLNC byculturingthem in vitro withrll...4. a prototypicalTh2
cytckine. It also examinesanyendogenous C)'tolcinc productionby thethyroidgland in normal
miceusing RT-PCR. Both the originalTbl cellpopulationsandthe Th2 cellpopulation produced
were to be adoptively transferredinto naivemiceandtheireffectonEAT assessed both by
hi~oIogy o( andcytokincmRNAexpressionin the thyroidglands. ThenonnaI murinethyroid
glandb.tsno endogenouscytokincmRNAexpression Ho_ . Tg-peptide-speeifieTh2 cells
could DOt be producedusingrn. -4 In "'tro.ThepropmyoenA IS an autocrine growth factor
may haveaffea:editsabilityto switchthe e:ytokine profileer n1 cells. and retaintheir antigen




Experimental autoimmunethyroiditiJCEAn is inducedin susceptiblestrainsof mice(H-2k
IDdH-2")CoDowingcllallenge _ Tg io CFA. TheTg peptidesTgPl (rTg(2495-2SIO) and TgP2
(rTg(2 695-2 7 13)] mohavethe obility"' ioduce EAT, and act u _ epitopes
(Chronopoulou and CarayamUotis, 1993, !lao et II., 1994). Many organ-specifi< outoUnmune
diseases, such u thyroiddisease. multiplesclerosisandinsulirHSependenl diabetesmellitus are
thoughl to bemediated byCD4+ T cells,andThl cdls in particular. CD4+T cellsdifferentiate
into two dislinctsubsets, with Th l cdls producing n.,.2 and IFN-y and UM>Ived primarily in ..u
mediated responses, whileTb2 cells producethe c:ytokiDes n...... n.·I Oand 0...-13 andare
typically involvedin bumonJraponses (O'Gan. andHoskm, 1997),
1111 and Tb2 cdls are cross-regulatory, meaningthat e:ytokines producedfromone subset
havetheabilityto downregulate theresponse of tile opposing subset. Theobjectivecrmy
l"e$CUCh was to induce anTg-peptide-specificTh2population by thedeviation of an established
Th l cell population usingthe Th2 cytokine ll..-4, andto ex.aminc the effect of tile Tb2 subset on
theinductionandprogression of EAT in SJUJ mice. TbcmelhodI usedwasbased on the work
by Kborutset aI. (1995 ). In their experiments in the EAE anima!model for MS, theyimmunized
micewith an enc:cpWtogeNCpeptidePLP(139.1SI) in CFAandafter 9·11 days in vitro,
remo ved the LNC. whichwere o ftbe lbl phenotype . They then proceeded to ' switch' these cells
from. !hI to a Tb2 pancm ofcytokinesecraioobytheadditionof rll..-4in vitro. Theythen
exomined thedUea>e-U1duciDg pot ential oCThl ondTh2 cdls io theEAE acimaI model,by
adoptive transfer into syngeneic Sn.JJ fcmale mice. Weatt empt ed to reproducethis protocol in
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the EAT model. usins theth)TOiditOlcnic pcptidesTgPl andTgP2 u antigens.
3.3 RESULTS
3.3.I1bt~ is DO detectable IIlRNA ror the cytokincs IL-l. fL.4 or IFN-y in normal thyroid
ped.
The measumncnt oftbc imnthyroid&J cylokine mRNAaimedIt establishing. baseline
such that in later experiments., the mRNAexpressionofe:ytolcines in the thyroidglandsofmitc
c:ouldbe usedto indicatea 1b I or lb2 type of response. TennormalSJlJ1miceWU'e tested for
the PRSCllCC ofimrolhyro;dalmRNA fo<the cy1OIriDe$ JL.2, IL-I and1fN..,. ThemRNAwas
extracted from the th)ToidRJand of S maleandS femalemiee, alongwith • similarsizepiece of
liverandspleen. ThemRNA wasusedto produceeDNAwhichwasllllplilied usingRT-PCR. and
viewedon an agaroscgel.~ SCCIIin Table 3.1, of the ten SJLIJmicetested, noneshowedthe
preseeceofJL.2, n.. or 1fN.., mRNA. y<tallshowedthe preseece of the lXXlSlitutivc enzyme
GAPDH and thyrogJobulin (FIpFe 3.1). As. conuol mRNAwu cxnaed from both spleen
andliver. Ofthc mRNA extractedfromthe spleen,most mice(6 of9 tested) showedthe presence:
oen....,wtill.e 2 of9 showed the presence ofn...2 . None exhibitedIFN-yexpression. Screening
oeliver mRNA showed simiJ&r results (data nocshown).iDdieating that there is expression of
cytolcine geocs in sometissuessuchas Iivcr andspleen. but DOne ill normalthyroidtissue. This
lndicalesthat the levelof cylokinc: mRNAexpressionc:oWd beused to detect the Tb subset
present in glands that havebeeninfiltratedafteradopti'Vc transferofTg-peptide-specificThl and
Tab le 3.1: Comparison of endogen ous mRNA leve ls in SJU J mouse thyroid and spleen, as
assessed by mRNA isola tion, cDNA preparation and RT-PCR·
Mou se SeA-
T1IYROID mRNA
GADPII Tg IL· 2 IL·4 IFN-y
SPLEENmRNA
GADPII Tg IL-2 IL-4 IFN-y




M + + • +





:; 7 F +8 F +
9 F +
10 F +
• Thyr oid and spleen tissue and mRNA extracted, cDNA prepared as per Malerials and Melhods.
RNA purity (as assessed by Am/A n , ) ranged (rom I.S-2.7 (or Ihyroid tissue and 1.4-2.8 (or
spleen ussue.
-+: Male mice ranged (rom 20-2S weeks old while female mice ranged (rom 6~7 weeks old.








Figure 3.1Representativegelli-omRT.peR of male SJLJJ thyroidgland
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Tb2cdIs .
3.11 TaPl • •• d Tcn...peciIk 1111 C)'toldae leCftIiaC edIt.~ produced ;1IvitnJ witbout
the use of "OCfaOId cytoldatl.
Following imtwniz.ationofmice with either ofthe thyroicfjtogenic peptides..TgP) or
TgP2, singlecell suspensions ofLNC werecultured in vitro with the corresponding antigen.and a
proliferation assayperformed (Fipre 3.1) , andsupcnwants takenat day I. 2 andJ for eytokine
analysis via C)'tokine EUSA. The proliferati on data(Flpre 3.3, A and B) indicated thai LNC
frommiceimmunized withTgP1 or TgP2 showedsignificant proliferation in responseto the
appropriateantigen. TheELISAresults (Fipre 3.3, C andD) showed antigcn-specific:
productionofthc lbl eytokines n.,.2 and IFN-y in LNC from mice imm.mized with either TgPl
or TsP2 . However, thellIlOUIllofcytokinesproducedin respoese to TgPllIld TsP2 differed.
In TgPl·primcdLNC, the amountofn...-2andIFN"Tproducecl in responseto antigenpresentin
culture wu significantly higherthaDthat with TgP2-primcd LNC. Thesedau. suggest that
pathogenic T8 pcptides differin theircapacity to activate T cellsto q'toDne production. Further
restimulation of cdls in vitro with the corresponding peptide allowedthe differentiation of
peptide-specific ceOsinto the ThI subsetas assessed by eytckineand proliferation data (not
sho'WD.). Thedataindieate that imrDmiDtion of micewith T8 peptides in CFA followed by
rc:stiDwWioIl. of drainingLNC In vitro with the corresponding peptide leachto the genention of
Thl cells. Thisis the first directobservationthat thyroiditogenic peptidesactivate ThI ceUs.




(from Khoruu .tal. 1995)
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Figure 3.2: Sc:bematic: drawing of culture coDditions of LNCfrom
mice immlUliud willi TgPl or TgP2
Figu re 3.3 Detec tion of Th I-type cytokines in the culture supernatant of LNC from mice immunized
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cy tc ktne co ncentration (ng /m l)
cytoktne co ncentratio n (ng /m!)
Cytokine ELISA (C,D) and prol iferation data. taken on day 4 (A , B), of LNC from mice immunized
with the peptide. LNC placed in vitro culture withou t any exogenous peptides at a co ncentration
of 5 x I 06 ce lls/rol. SO <1%. not seen on graph . Backg rou nd CPM values are , for TgPI 2883 (A)
and for TeP 2 is 3238 (8 ).
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In otherexperiments,theLNe removedfrom miceimmunized witheither TgPI or TgP2 were
highlyprOOf...... ;" !heIbscna: of peptide, IS dldieatedby highba<kgrowld CPM in
proliferation. assays (dat.aDOtshown). Theadditionofrll..-4 to culture seemed to acccfthWethis
increased proliferation. For this reason,a stUdyof the IrinetiQof theproliferation ofLNC from
mice immunized withTgPl wasperl'onncd (F1p" 3•• ). Jt indicatedthat theLNe were highly
prolifentiveforup to 10 days of secondary in ""ITO stim11ation. Althoughthe responsewithrlL-4
in cultw"eappeanlower. as expresxd by stimuWion indecvalues.the bKkground countsare
aetuaUy manytimeshigherthanthebackgroundcounts for cultures containingno exogenous
cytokines . On the basi$of thesedata, we decided to Ql/ture LNC for 10 cb.ys instead of 4 days i n
""tI"O as Khonrtset at. haddone (See rip " 3.1), thus modifying our originalprotocol .
3.3.3 Addiac u . _ou. rDA i. vilnIto LNC from mi« imlDuaizcd with TcP l or TeP1
does Dot produce peplidMpeeirtc 1b2-<)'tokiDe I«rttiaC tdls alt er 10 da ys in cu ltUI"t..
Aftermodifying the originalprcroccl tc secondarily 5limu.Iate LNe for 10days. with rn.A
added only;" one 30 nglmldose,!he prdcmltial productionof largeamounts of!he Th2
q10lrines ll..-4andL IOwasobserved(Fipre 3.! ). However, thisC)1okine produaioa was not
antigen· specificbecauseit waspresentalsoin aJlturcs that did DOt contain TgPl. This loss of
antigenspecificity may bedue to the LNCstimulation ofrlL-4 in an autocnnefashion. It mayalso
bedue to the rfi....4acting on other«Us in the LNCsuspension,downregu1aring the cells of the
antigCfto'specific lb l subset and stimuJ.ating the proliferation orother. non-uttigcnspec:i&uU
types . In subsequent experiments we ' rested' the LNC between primaryandsecondary
"Figure 3.4: Kinetics of proliferation of lNC from mice immunized with
TgPI
10
• S.1. <TIP' )
o S.J. (TI Pl/ rlL·4)
Stimu lation iadex
Mice were immunized with TgPt in CFA. Nine days later. the draining LNC were
cult ured in vitro with or without exogenous rIL4 in the absence of antigen.
Proliferation assays were performed OD day 4, 1 and 10 as indicated on the y
axis. Background CPM values were as follows: for TIPt only: 709 (Day 4), 662
(Day 7), 146 (Day 10); for TgPI + rn A: 3S39 (Day 4), 4328 (Day 7), and 3133
(Day 10).
,.
Figure 3.5: Production of cytokines by LNC of mice immunized with
TgP t and cultured in vitro in the presence or absence of peptide with
t1L-4
~ I rL-4 . TgP1 Conc:Q.·Z (nllllll )
s
I ConcIfN., {.,ml)~Q."" (IIJIIIlI )
s r1L-4 + TgP 1 Conc:o..IO (nlfln!)
Cone Cyt. .... (ngtmQ
Five mice were immunized with 100 ~g of TgPt per mouse.
Subsequentl y. their brachial . inguinal and auxil1ary LNC underwent a
secondary stimulation in culture in the presence of 30 og/mt of rIL-4
wi th or without TgPt. The quantitatioD of the indicated cytokines in the
culture supernatant (at day 10) was assayed by sandwich ELISA. S.D.
<1%. Dot visible on the graph. Results arc representative of 3
expe riments.
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stimulation in \litro(see F"lpl't 3.2) . They WU'e culturedin the absence orall cylolcines and
antigens (or 5 days.. after stimulationin culturefor S days. Thisagainresulted in highproduction
oCTb2cytODoes IL-4 and«'-10 (F"tp re 3.6), thatwasagainnot antigen-specifie. This was seen
whennUce were immunized wrtherthcrTgPl (A) or TgP2(8 ), ;" rclatively"lIJa! unounlS. This
mwe:ato<! thatTgPI or TgP2 • specificTb2 ceIh lXlUId no<beproducedusingtIUs prolocol. As
our objectivewas to use Ta-peptidespecificThl andTb2 celJs in biological~ts. we
decidedto abandonthe productionaf Ts-peptide speciJicTh2 c:eIls by this method.
3.' DISCUSSION
TheobjectiveoCmyraardl has been rwo-CoId , I ) to produce I Tg.peptide-specific Tb2
ceIJ. population andb) to adoptivelytnnsfcr TS-pepti6e-spccific Thl and Th2 cells into S1I.JI
miceandto determinetheiretrect on EAT developmcm. An imponant prerequisite to studying
theeffectof Thl and Th2 cellsin the thyroid glandduringEAT is to determinethe background
levelsoCany cndogCllClUS eytokineswrthdtthe nonnalthyroidgland Analysisby RT·PCR shoW«!
that thereis no mdogmous production ofmRNA (or the Thl eytokines n..·2 or IFN-y or the lb2
q1okine5., IL-4or fi...l0 . This would faciliw e thedeteaion ofintmbyroidaJThl or Th2 cells,
followingadoptivetransferafTg-specific Thl or Th2 cens intonaivehosts.
Thepresent datadirectlydemonstratethat LNCfrommiceimmunized with
thyroiditog.... peptides ;" CFA ctilfe<eotiate by def'&ult iotoTb1cellsuponsec<>n<Wy stimuWioo
in cu!tlucwrthTgPl andTgP2. Most oCtheraardl impIie:ating the role cf'Thl cellsin EAT has
beenindi.rea. It hu beenshownthat injectionofThl..mducing q10lcines such as ll..-12 (ImIey-
Figure 3.6: Production of cytokines by LNC from mice immunized with TgP I or TgP2. with rlL-4 in














• IL · IO
o IFN'T
g
Co ncenlra l io n (n./ml ) Co ncc:nlu l io n (AI/m l)
Mice were immunized with 100 .... g of TgP I or TgP2 in CFA. Draining LNC were cultured in
vitro with r1L-4 added to cultures at 30 ng/m!. Afler S days in vitro. live cells were
isolated, and cultured for a Iunher S days in the absence of Ag. with milomyci n-C
treated splenocytes (APC) as reeder ce lls. They were restimul ated after S days whh
peptide and fresh APC. S.D. <1%, not visible on graph . Each graph is representative of S
experiments .
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Mullen et aI., 1991) andIFN-y(Rc:mye aI., 1987) promote the dC'Vdopment or EAT, while
prototypicallh2 c:ytokinessuchu U,lO (MignotHJode&oyet al., 1995)have. curativeeffect
on EAT . Cell linesandcloneslhaI transferEAT fromthyroidlesionsfromT-een depleted
(CS7BU6xCJHlHe)FImicealsoproduceThl C)1okines (Sugiharaet aI., 1993). However, ours
is the 6m study that indjeatcsthat immunization with TgPl or TgP2 inducesLNC thai produce
Thl eytokines in responseto the pathogenicpeptide;1Ivitro.
TbescThl cytokifle..producing LNC could not besw1tched to produce Tb2.rype cytolcines
in the presence of exogenousrll..-4 in vitTO. FII'StIy, LNCremoved frommiceimmunized with
TgPl or TgP2 archighlyproliferative for up to 10 daysin die absence ofeither peptideof
exogenous eytolcincs. Addition of rn...-.4 in vitro acccntuIted thisproliferation yet did not mediate
• mlth in cytoldncsecretionofttle LNCafter4 daysof culture. DA has been shown to inhibit
C)'tokine productionby lbl cells(FiorcotinoClaI., 1989, Pelemanet at. 1989, Vieira et aI.,
1991). IL-4alsoshares features with the prototypic:al Thl cytokine n,...2 in thatit is an autocrine
growfactorforT cells(Kupper Cl aI., 1987). Thiscould allowforLNC thatwerealready highly
proliferativein vitro andproducing highamouDtS DeL2 indepcndCld of thepresenceof peptide
in cultureto haveenhanced proliferation following additionofrn.-4 . As this increased n. ·2
productionlprolifcntion wasnot demonstratedby Kboruts et aI. (l 99S) who immunized mice
with PLP(139-ISI) , one could assumethat thisfindingmay be due to a prcpety of the
Unmunizmg peptides,TgPI and TgP2. Both TgPI. (ChrollOpoWOU and Canyanniotis . 1992)and
TgP2- (Cuayanniotis er &I., 199<1) spcQfi~ LNC haveshownsum g prolifentive responsesin
"tro, and the response of TgP ttrgP2 and PLP( 139-lSl ) basDOl been compared . However,
prolonged incub&tioIlofLNC with rn....-4. or even• rcsbng of cdls betweentint and second
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antigco stimulation in vil1'O. did not genente As-speci& Th2"Us. Therewas an Mease in the
D..-4 andIL-IOin culture. along with . corresponding decreasein 1L-2andIFN-y , but therewas
no antigenspecificityin theseresponses. It is possiblethat after long term culture with ll..-4. an
autoaine growth factor, cells are stimulated to proliferate andsecreteC)1okines in the absenceof
antigen.
In someof the experimentsexploring the effect of Th2 ecUson fbi-mediated
autoimmunity, the Th2 ceU, used were not &utoantigen-specific. Du et aI. (1997) reponed that
the generation ofTh2 clones specific:for PLP(I J9-lSl) met with limitedsuccess usingc:ytolcines
in 0J1turc. They usedtwo techniques thatmay haveworked in our model. ODewas to foUow
immunization withPlJ'( 139-1SI ) with an i.p. injectionoftbe monodonalantibody anli-B7.1. The
secondwas to use a morecommontechniquefor producingTb2ceUs,alteredpeptide ligands
(APL), TheseAPL are produad by. single.... substitution that produces. partialagonist
(lafail!<. 1998). nus approadl has not beenIn-,ed in die EAT modcI,yet in die EAEmodel,
APL's havebeen successfulin producingTb2clones. Oas et 11., 1997 used the APLof PLP(139-
lSI), Q I44. that was previously shown to improvediseaseoutcomein SJL femalemice
iJnmwDud with..... PLP peptide(W144) in CFA<N- .. Ii ., 1995). Other oxperimemJ
shewed that the APL LI44IR147 liso protected apinst EAE(Noeholso" eeal., 1997). Ahhough
Th2 eytokine production could DOt bedirectly implicated in the protective effects of these APL'S.
both the cytolcincpro61eof d ones producedusingAPL and• sepame RUdy showingthat the
prot ecnveeffect of APL's couldbeabolished byanti-IL" mAbs,(Brock, et Ii ., 1996) stro"81y
inferits involvement.
Th2 cellscanalso be producedby the useof C)1olcinc-spec:i1ic mAbs that downregulate
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Thl cellsduring LNe culture(Astrup et al., 1997). Forexample, adding anti-Ll2 along with the
Th2 tylolcineIL-4to. culture ofLNC will both promoteTh2 development (IL-4) while
prt'Yattingthe abilityo(any n..12 in culture to promote I lb.1 response (ann.n... t2 AbXAusmlp
et aI., 1991). A similarapproachmayhaveworkedmour modd .
IL-4 hasbeenshownto have. protectiveeffectin severalmodelsof organ·specific
autoimmunity, including EAT(Racke et al., 1994),but only if'appliedearlyin the preclina! stages
ofthc disease. In our study , TgPt· or TgP2-spc:c:i5c T cdls were probablyalready wmmined to
tbeThIIineage, and the added fi......4 inc:uJtun: could not reversetbise:ff'ea(Rackeet al.• 1994,
Gijbelset al., 1997). In addition.. protectiverole for D.A in EAT has not beenconclusiveJy
confirmed. On the otherband, theTh2 cytokincfi....l0mighthavebeen. mud! bettercandidate
for!IUch cxperimenu. n..lO bIodcs~ effectorNnaion.andas Thllnduced
mflammatioD ismediatedmostlythroughactivatedmacrophage$., n...10is. narunJcandidate asI
downregulatorof lbl cells(Lafaille,1998).lndecd, nAO hasbeendemonstratedin vitro to
downregulatca Th1 response(Lafaille. 1998). In the EAT model,rhIL-IOhasbeen implicated. in
the enhancedcelldeatllofT Iympbocytes" EAT lesioos(Mgnoo-Godefroy .. 11., I99S)and
both In vim administration and plasmidadministration oeo..-IO badthe effea ofbcth preventing
andcuring establishedEAT (Mignon--Godefroy et aI., 1995. Battcux et &1., 1999). For these
reasons, in the EAT modelinununedeviation mightbe more successful ifn.·l0 wasused instead
ofl1.-4 .
Are antigen-specific Thl cellsaetualty being switchedby the addition ofrlIA to a.l1nae?
After the additionof rn...-4 to culture.~s proliferaleregardlessof Aspresenceandproduce Th2
cytokines. Thisculturecontainsa heterogenousmixof cells. Underconditionswhereno
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ecogeDOUS cytokiDesareadded. Ag-specific LNC produce C)101cines in theirspecific response to
IJttigen. 11is possiblethat the rD...-4 in culture dowrngulates productionof antigen-specificTbI
~s while it stimulates other cells to prolifcme., producing Th2 eytokines. The beteroseneity of
evenhighlypolarized ThI populations hasbeen shownat the singleccUlevelusingflow
c:ytomeuy(Murphyet aI.• 1996) , In thefUtu.R. Thl and1'la c:ells mayalso be able to be sorted
basedon surface marken such IS CCRB (Zingoni CIal., 1998),CCR4. CCRS(Bonnecc:hiet ai.,
1998) or CXCRJ(5_ ." ol , 1998).
It remainsunclearwbetberadoptive mnsfcr ofTb2 cdls canbeeffective in treatingTb1-
mediated autoimmune disease. Cytokineshavebeen shownto bebeneficial in manyanimalmodels
of autoimmunityI yet thismethod is impractical for human uscbecause it calls forlargequantities
of cytokines whichhavea soon halflifein \1\10andoftencauseserioussideeffectsto the patient
(Thomson, 1996). Although the effectofTb2 cellsbasnot been dired.lyassessed in EAT, studies
in othotc a<pD-specific _ mod~s ha.. DOl beenproIIlding (reviewed in WaiDe, 1998).
In manyeases,ccHnjectioft of Tb1andTb2cellsbasbadnobene6ciaI effecton disease
progression,even whenTh2cellsare in )l).foldexcess(Katz d al., 1995,Kbotuts et aI., 1995).
Several other experiments (Cbenet aI., 1994, Kuc:hroo et al., 1995) have shown Tb2 cellsto be
protective if the autoimmunitywasIttempted to be inducedafter the injectionafTh2 cdIs. Thus
fromthese results,it seemsthat Th2cellsare effective in pm-enbnSa Th1 responsein naivehosts
yet are ineffective in controllingthe effectorfunctionsof activatedThl cens, Thisquestionsa
putativecurative roleof Th2 celli in organ-spec:ifi.c: IUtOimmunity.
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3.S FUTURE DIRE CIlONS
Thedf'ect afTs-peptide specific Th2cellson thedevelopment orEAT remainsanopen
questionwbicbcannot beansweredunlessI reliable method for producing1b2 cellscanbefound.
Onepossibilityis to use. c:ombination of Th2 e:ytokines such as IL-4 and/or IL-IOand mAbsto
Tbl-inducing t)'tokincs such as IL-12 andIFN-y. In addition to assays ofeytolcines in cuhurc
supenwant1, usays for Th2cellmarkcn such as CCR8should be used to verifythe Th2 cell
induction.. Other methods to produceTh2 cdls should alsobeexplored.includingthe successful
method ofusing APL's ora givenpathogenicepitope . As this study aimed to reproduce: a
sua:essfW protocol &omanother modelwherebytheproduaiooof DC'Wpeptides wasDOl
required. the useof APL's wasnot ancmpc:ed.
Therole oCTh2cellsas a 'cure ' for I Thl-mediated diseasedocs not seem. however.
promising&omresults fromother IUtOimmune diseases(O'Gam et al.• 1997), andother
thetapeutie approacbes to immunedeviationshouldbeinvmigated. There is the possibility that
othertypes ofT cellsmaybeinvolvedin the breakdown in lmmuoortgUlation associatedwith
orpn--spc:c;ific autoimmunity. For e:umple. I third type ofT belper tcU. Th3 which secretes large
amountsofT GF·p 1 andlowamountsofnA, DAOandIFN·y may haveaneffecton
autoimmunityas it is believedto have • role in oral tolerance (Chen et al., 1994). Theremay also
beanother type ofCD4 + T ceOtype. seeming highn-ro.tcw IL-4 andTGF4l calledT
RgUlatory cdI l (Trl )(Groux et al.,1997). TheCXllllbUIatio. ofn.- IO&lid TGF·p ' eems tc have
• role intheprevention of colitisin I.D adoptive transfer modelandprevents IDOMin young
NOD mice(Han d &1., 1996). These cel lstypes should be explored in the EAT modd. Exploring
S6
the role of tbese types ofcdI s may leadto. better understanding ortbe complex network ofT




AN ALGORITHM·BASED APPROACH FOR MAPPING A'-BINDING
PAmOGENIC THYROGLOBULIN EPITOPES
UABSlllACT
The mappingof pathogeniccpitopcs in autoantigenshashelped in the undemanding of
pathogenesis and possibletreatment of autoimmune disorders. In earlierstudies.T8 peptide.
bindingto Aawas shown to be. prerequisiteto T cellactivation andthe I·A subregionbas been
implicated in thegenetic:comrolin EAT. Here.we haveused In aJgol'ithnHlased approachto
W1emifY five rTg pcpeides _ A'-biIldiDg potential. TIn< """" orH.2' oace (CBAII. AXR.
andOHlHd) werechaUengcd with these peptides andthe capacityof these antigens to induce T·
cellandAbresponses. u well u EAT wasexamined. Oneof the peptides,18(2597-2609) has
emergedIS• pathogenicepitope. inducingpeptide-specific serumIgG Abs. andmononuclearcell
infiltration olthyroid, in all threestrainsof mice. However. T cell ac:tivarion ;1IvilTOby cylokine
detection in culturesupcmawrt or prolifcntion in response to the antigen was not detectu1 for
reasonsthat are still unexplained. Thisstudy hasconfirmed thai algorithms dw predictbinding of
peptidesto Aaare successful. in predictingpathogenic T ceUepaopesofTg . Application of this
andsimilar algorithmsto the recentlypublished mYgsequencemay leadto the discoveryof
ftu1bc:r T cell epitopcsin EAT.
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U INTRODVCI10N
18 hasbeen impIiClledIS theprinwy autoantigcnin the pathogenesis ofexperimental
autoimmunethyroiditis. As T8 is. largeaueoantigen(homodimer. MW 660 WI) rt is likelyto
encompassmany pathoSenic T cell epitopes. Currently,fiveT cellepitopesofTg havebeen
mapped (Carayanniotisandbo, 1997) but an immunodominant epitopeis yet to bediscovered.
Thedit<overyornew epitopes mayhelpin theundenaodingorthe mechanisms or AlTO Uld
bow immune tolcrmc;eto theseselfantigensisabrogaIed.,1eading to autoimmunedisease
8-2' miceare susceptibleto EAT roUawing immunization with T8 and thus 'good
responden' to EAT induction. TheH-2controlorEAT has beenlocalizedin the I-Asubregion
(Beisel. andRose., 1983). For this reason. peptides ofTS that biDdto A or E molecules ofH-r
miceare possiblecandidatesfor pathogenicT cd! epitopes.
There are several algorithms that predictpeptide bindingto the A~ or E~ molecules . The
objectivearmy researchwu to use oneof thesealgorithms(Altuviaet &1., 1994)to scanthe 18
moIee:ule for peptidesthatmaybindto Al . ThisalgorithmCOD1Iined two motifs, A andB. for
screening peptidebindingto MHe. Fromthisinitialscan, peptidesthatcontainedovahpplng A
andB motifswereidentified. Thesepeptideswerethen tested in three strains ofH _2l micetAleR.
CBM andC3H1HeJ)for theircapacityto bindto the Al andEl mclecalesandinduceT-cell and
antibodyresponsesas wdI &Sfor theirabilityto induce EAT.
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4.3 RESULlS
4.3.1 AJcori.ll aHtued pred ictioa orln~. TI ptp Cida th at biDd to A~ moIeaalet
Thelast 967 .... stretchofrTS wu scannedusing the motifs A andB outlined in T. ble
2.1, usingpdlENE 50_ . ThiSl ..,,:b resulted ;" 29 peptides lNt 6t motif A andl7lNt 6t
motifB, andwe selectedpeptidcsthatfit both motifsA and B. Sevenpeptidcshadcompletely
overlapping motifs(fable 4.1) while sixpeptides were fOund with pania1Jy overlapping motifs
(T." '.2). For reasonsof economywe focusedon peptidcswithcompletelyoverlappingmotifs
andfivewerechosenas newcandidatesfor mouseEAT induction. Two were previously
documented IS existing pathogenic T c:dJ. epitopes : peptide(2494-2500) is . portion ofTgP l
(249S·2SII ) (CbronopoulOll and Canyannioti~ 1m) and peptide (2S47-2SSJ) is panof the
peptidedesigrwed T.(2S53) (Hutchingset &J., 1992). Subsequentto the synthesisof these
peptid~ the mTsscqueocc"" published (CalurcgIict 01.. 1997). This _ ..... wu oIso
scanned using motifs AandB. andA'.bindingsequences weresimilarly determined(T a ble 4.3
and Table4.4). These_ ..... included IMll}' p<edi<ted.....Sthe rTs lOOlcculc, plusothers
foundat the N-tenninalend. The algorithmderivedfrom features of tbe crystal structure of A~
(Freemont et aI., 1997) was also usedto SCIJI both the mTg andrTg sequences (Ta ble ••5) and
sevaaI oflbcsc sequenccsova1appcd with~ froIIl the otheroIS_ and arc DWkcd in
the respectivetables. Thesepeptidesare also goodcandidatesfor T cell epitopes in H·2' mice.
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Table 4.1 : Prediction of Ak-bindin g T cell epitopes within rat Tg



















'Ii' Coordinates corr esponding to a.a. positions within the mature
hTg polypeptide (does not include leader sequence)
* Sequences delineated by motif A are represented in bold letter s.
Sequences denoted by motif B are underlined .
•• Indicates motif also found using algorithm from Freemont et al.•
1997 .
Table 4.2: Prediction of Ak-binding T cell epitopes within rat Tg
















* Coordinate s corresponding to a.a. position s within the mature
hTg pol ypeptide (does not include leader sequence )
* Sequence s delineat ed by motif A are represented in bold letters .
Sequences denoted by motif B are underlined .
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Tabl e 4.3: roTg sequences predicted using algorithm from Alluvia et




107·121 yapv QC.IlI.JlRY qcwc
224 -238 rela EIGLEll. ldei
228 ·242 etgl ELLLIIEl ydti
306-320 yqtv QC.Q:[EIDd CWtV
824· 838 qdYp~npp
837 -851 ppge !'JlELIlEYifwq
1577·1591 " spiv QCI.lDCA Dde.
1823· 1837 dfpg nMA:IELE spvd
2025- 2039 cgse Il:IEYlIIY pfgw
2 103· 2 117" smaq D.ECLQQC srhq
2490·2 504 gsqd nGLUlRA ltay.
254 3-2557 yysl EHllIlDY asf,
2595· 2609 e'yg HGSLELL advq
Mouse Tg sequence from Caturegli er al .• 1997. containing the
leader sequence. Motifs A and B from Alluvia et aI.• 1994. mTg
sequence scanned with motif A and Busing pcGENE software.
Underlined sequence denotes sequences delineated by motif A while
bolded sequence denotes sequences delineated by motif B.
•• Indicate s that pan of this sequence was also predicted using the
algorithm found in Freemont et aI.. 1997.
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Table 4.4: mTg sequences predicted using algorithm from Ahuv ia et




30 1-318 hrdg IIYQIQCQTE gmcw
824-842 qdvp QVVLEOA:IIEI! geni
869 -887 mple IIEl!lLRSCWCVD eagq
1020- 1038 pvqc HAl:lIQQCWCVD gr8e
1049 - 106 7 sqmp QCP nu:El.S&A sgti
1385-1403 sgrf QLBI nSKTfSA dttl
1572- 1589 •• vpsa DSE:L.YQCLTO caod
2025-2041 cgse DTEYIlIYI!F gwyq
2113· 2131 csrh QDCLYI:I'LQIQ pgvv
2114·2131 srhq lll:LllIn.QIQ pgvv
2 119· 213 7 <Ivt nQ~vtyp
2290· 2308 gsgg QLTIOOSILAA vgnt
2420-2438 vgcp TSSIQEllYSCL rqtp
2562 ·2579 nau CYEJ.IC.fMVN masl
mTg sequence from Caturegli ct al.. 1997. with the inclusion of the
leader sequence. Sequence scanned using pcGENE software.
Underlined sequences denote sequences delineated using motif A
while balded sequences denote sequences delineated using motif B.
•• Indicates sequence predicted using algorithm from FremoDt et aI.•
19 97
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Table 4.5: Tg sequences predicted using an algorithm for peptide














• mTg sequence aligned with rTg partial sequence using PALION
software of pcOENE and sequence position taken from this.
Sequence in capital letters denotes motif. Sequence position includes
the leader signal sequence.
MOTIF FROM FREMONT ET AL., 1997:
D-X-X-[ILVNj-X-[EQ) -{IIRK}-X-[STRQAG]
[] mean to include the amino acids contained within them.
{}mean to exclude the amino acids contained within them.
X means any amino acid at that position
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o.z ne rT. pepdcIes foaad lUiallbe aIcOritb.. aft lticbIJ ltomolOCOUJ t. the
corretpolldia,IDTa ~tides.
TherTgsequences predicted usingthealgorithm forAk.bindingpeptides werecompared
to the recently publishedmTg sequcuce (Caturegti et aJ..1997). As seen. ill theTable...6. aCthe
rn:peptidcs scIcacd, CWO [rTIll2029-2040) and rTg (2197·2609)J _ . completelyhomologous
to the comspo ndillgmTg sequence, wbiI. ooe [rTIll21()8..2121») wasIUghIyhomologous
(94.4%) to mTJ.Only ODeLa. wasdift'erart between thetwo peptidcs. andthemYg sequence
conWnedboth A and B ll>l>tif1 Two peptidcs[ rTg(1827. 18l 7) andrTIll2424-24l7) J Iwl .
corraponding mYgpeptidewhich did not contain themotifs from A1tuvia et 11. (1994)andwere
not identified byseanrUng themTgsequencewiththealgorithm (Table4.4). In thecorresponding
mYasequence forrTg(1827· 1837)therewas. gapinthemousesequence inserted when mTg
wasaligned_ bTg or bTg (Catureg/iet al.,1997). indiwing tbalthe mTg lequenceIw.
dd etioo ofthesctwo La.
4.3.3 The peptide TI<1597.2,") biad, .troDJIy to the A' moleule, wllile T&<2..2....2437 )
biad, stroacfyto tbe E' molecule.
We first examined therelative biDding of eachaCtbepeptides to MHCvia• competitive
mhibition assay. ThisassayusedeitheranA'.or an~ -rcstric:Iedhybridoma{3.47 and8F9
respectivdy) recognizmg T~211l) and TgP)~Y. on TAJ cel1swbichexpressA' and E'
molecules. Inhibition ofT -ttU bybridoma activation wasthentested inthepresence of increasing
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Table 4.6 Homology comparison of rTg peptides with putative A'-
binding capacity selected using A' binding algorithm to
corre sponding peptides of mTg'
Sequence position sequence 'homology
rTg (l827-18 37) EGADMATELFS
mTg (l82S-183S ) PG_ MATELFS" 72 .3
rTg(202 9-2040) GSEIl'lEVHTYPF
mTg(2026-20l7 ) GSEIl'lEVHTYPF 100
rTg(2108 · 212S) llR:l.QEC5RIlQIVI1L
mTg(2107-2124 ) DR:LQQCSRHQIlCLVI1L 94 .4
rTg(2 424·2 437) NSSVQEVVSCFRQK
mTg(242 1-2437 ) TSSI QEVVsa.RQK 78.6
rTg(2S97·2 609) YGHGSU1l.'J)VQ
mTg(2S97· 2609 ) YGHGSU1l.'J)VQ 100
• Peptides chosen using algorithm outlined in Altuvia et al.• 1994.
MIg sequence is from Canuegli et al., 1997.
.. within the published sequence for mTg, there are gaps whicb are
designated by an _ in the sequence. These gaps were iasen ed during
the alignment of mTg with other Ig (Caturegli et a1.• 1997).
Sequences that are Dot identical in both sequences are in bold in the
rTg sequence
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ImOUIItS of tbe inhibitor peptide. AI shownin Frp~ "...d Table ...7. theonJypeptide to
show drastic inJubition of theKtivationol 3.47 wasTg(2S97-2609) (shown as anopen triangle)
with an Ie,. valueer ro mM Themoux lysozyme: peptide(46-62)~2) is. knownA'-
binder that was usedIS.positivecontrol, with an Ie.. vaNe of8 JL'i . Slight inhibition was also
seen with Tg(2424- 2437) and1 8<2029-2040). Theseresults implicate Tg(2S97-2609 ) as a
m.livdy stroIl8 binderto the A'_.
All peptides slightlyinhibited theactivation of 8F9 at highconcentrations (Figure ••1 aDd
Table 4.7) yet the pcptidescaD bedivided into strong, mediumandweakbiDders. Thepeptide
Tg(2424-2437) stro ngly inhibited 8F9's activation(Ie,. values oC20 IJM)and them'ore is the
strongest E' -binder amollSthe 19 peptides test ed. Next arc the peptidcs Tg(2029.2040) and
Tg(2597.2609)with lc"vaIues ofJS I'M__ Tbeothenwopeprides Ts(1827 -1837) and
rTg(2101-212S)maybindveryweaklyto E' as they onlyinhibit8F9 activation at the highest
concentrations
4.3." T ctll ralcdvity In rapoDse to tbe TI peptida
Theimmunogenicityof the TS peptideswasdetermined using prolifcntion assay and
cytokineELISA. Two miceper strainwere immunized with 100runolof the appropriatepeptide.
aDd9 days later. thedraining inguinal.auxiliaryand brachi&llympbnodeswerec:olleaed and
siDgieeellsuspensions prepared. TheLNC were thencultured in the presence of the inununizing
peptideand• proliferation assayandeytokineWSA preformedas outlinedin the Materialsand
Methods. None oCme fiveTg peptidcs induced significantproIiferuion (i.e. Stimulationindex
"Table 4.7: Results from ccmpeuve inhibition assays. indicating
relative binding of each of the Tg peptides to the A- or E~
molecules
Pept ide Ie so Values (mM)·
A' E'
Tg(l82 7-1837 ) >83 >83
Tg( 2029·2040) >70 35
Tg (2108· 2125) >42 >42
Tg (2424·2437) 52 20
Tg (2597-2609 ) 10 3 5
ML (46·62) NIl'"
• Binding to A- or Et was determined using a competitive inhibition
assay outlined in Materials and Methods. IC,o was calculated as the
point where activation of CTLL cells was reduced to 50%. Results
representative of 3 experiments .
•• ND = not determined
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Figure 4.1 : Competitive Inhibition Assay indicating Ak binding
in peptides chosen using algorithm
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Hybridoma cells (3.47. Ak -restricted. T4(2553) specific) were cultured
with the APe TA3 in the presence of T4(2S53) at O.OS IJ. g/m l. Increasing
conce ntratio ns of the Inhibiter peptide were added and activ ation of the
hybridoma was measured using CTLL assay. ML46-62. a peptide known to
bind to Ak was used as a positive control. The figure is representative of 3
separate expe rime nts.
"Figure 4.2: Competit ive Inhibition Assay indicating Ek binding in peptides










c eeeenerauon inhibitor (~ l/m l)
rT.(l11 7· tIl1j
____ rTl {2029·204 0)
•••• •••• rT. (2108· 2125)
-9- rTr<2424-~437)
••••• •• rT. (2591·2609)
Cone(1lMJ
Hybridoma cells (8F9. E' -restricted, TgPt-specific) were cultured with
the APe TA3 in the presence of TgPt at 0.04 mgtml. Increasing
concentrations of the inhibitor peptide were added and activation of
the bybridoma was measured using CTLL assay. The figure is
representative of 3 experiments .
'0Table 4.8: Immunogenic:iryof peptides assessed in H-2' str1iDs of
mice
CytokiD< ELISA(Dstmll
Pepcide Mouse Suain 5.1.' lFN·y n.·2 n.·10 n.-4
Ta OH <2 0.04 <0.04 <0.37 <0.04
( 182 7· 1837) AKR <2 0.1 <0.04 <0.37 0.08
CBAll <2 0.22 <0.04 <0.37 0.14
Ta O H <2 0.06 <0.04 <0.37 <0.04
( 202 9· 2040) AKR <2 0.06 <0.04 <0.37 <0.04
CBAll <2 0.04 <0.04 <0.37 <0.04
Ta OH <2 <0.49 <0.04 Nl <0.04
(2108 -2125) AKR <2 0.45 <0.04 Nl <0.04
CBAll <2 1.16 <0.04 Nl <0.04
Tg OH <2 0.13 <0.04 Nl <0.04
(24 24· 2437) AKR <2 <0.49 <0.04 Nl <0.04
CBAll <2 <0.49 <0.04 Nl <0.04
Ta OH <2 <0.49 <0.04 Nl <0.04
(2 597·2 609) AKR <2 <0.49 <0.04 Nl <0.04
CBAll <2 <0.49 <0.04 ro <0.04
Mice wereimmunizedwiththeabovepeptides andboth proliferation
assays andcytokine ELISA assayswereperformed asdescribed in
theMaterials andMethods. Detection limitforeytOkiDeEllSA wasas
follows: lFN·y : 0.49Dglml. n.-4: 0.04 Dglml . n.-2 : 0.04ollmLn.·l0
0.37 oglml . ND=not determined. C)'Ulkioo ELISAsetupseee
pedormedat 30 nmoVml of theappropri.aIe peptide.
• 10theproliferation assays, background CPMdidDO exceedtOOO in
ally of thecultures tested. 5.1.=Stimulation index.
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>2) oftbc LNC and therewasverytittlec:ytokineproduaion in anyof the LNC adtures (Table
U ). LNe cuInueof CBM micet1w were inlmuNzed with Tg(21Q8.212S) produced the
highest amount ofC)'lolcines,. most significantly IF'N..,.. Thedetection limitaCmeC)'Iokine ELISA
wasquite&OW, rangingfrom0.04 ng/ml for IL-4 and0..-2 to 0.37 nWrnJ for fi..l 0 and 0.49 ng/ml
for IFN~y. so any change in C)'Iolcine levelsin that range couldhave been detected. In addition,
the LowS.I. values could DOl beattribu ted to high backgroundCPM. The conclusionfrom these
datais thataoneofw Tg peptidessignificantly stimulateT c:dlscoeitherproliferateor produce
c:ytokincs in WtTO.
.u.s. Then wu Siplf'tCIIDt production . , leGu tibody ia rtSpo llH to Tc(2,uf .143 7) lad
Ta(1S97.1609 ) wilb Utile mtSI raetivily with mT"
The threeH.2' mousestrains(CBM , CJHllloJandAKR) were immwUzcd with oneof
the S peptidcsinCFA, andboosted 3 weeks laIerwiththesamepeptide in IFA. Fiveweeks from
the initialchallengethe serawere analyzed for the presenceof peptide--specific IgO. Therewas
lowbut significant amounts ofpqJtide-specific 19Oproducedin response to Tg(2597-2609) and
Tg(2424-2 437) (Fipre 4.3). Bothof these peptides fit the motifby Altuvia et aI. (1994) as At.
bindingpeptides yet onlyTg(2591-2609) wu shownto bea relativelystrong At binder (lC5Oof
10 ~\{) whileTg(2424-.2417) boundmorectrectivdyto E' ( IC50 of2 0 lAM)as eompared to Ak
(Ie. of 52 J,LM). Comparingthe threestrainsof mice.CBNJ produced the-highest amount of
antibody(as determined by titre in an antibodyELISA assay) foUowed by AKReuee, with the
lowest Ab response edlibited by OK mice. Therewaslittle cro ss reacti vity of the Abs fromthe
Figure 4.3 JgO anlibody from sera of k strai n mice immunized wuh peptides se lected using an
algorithm reflecting Ak hinding of peptides
~
A. rTg (2108-21 25)







c. rTg (2424·2437 )
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-0- AKR Three mice from each strain were immunized wu h the appropriate peptide ( 100 nmol) in CFA
--0- CBAlJand boosted with the same peptide (50 nmol) in IFA. Mice were bled 3 weeks later. Antibody
.•..0 -.. . C3tt ELISA was performed as per Maler ial~ and Methods. Panel A.e and E were from plales coaled
with Ihe designated peptide and panels B. D. and F were from plates coated with mouse Tg.
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sen. of mice immunized with anyaClhe T8 peptides to mTs.
The threestrains ofmicc wereimmunized witheither Tg(2108 -2125), Tg(2424-2437) or
Tg(2597.2609) in CFAandboosted with the same peptide in IFA3 weeks later . Five weeks after
the iMW chaIIense.the thyro;dglandswereranovedandhUtolog;calJy examined os outlined in
the Materials andMethods. Tg(1827.1837) andTg(2029-2041) werenot used'0 imo>mize mice
in these experimentsbecausetheydid not bind10 either At or Et (Tip'" ~.1 andFigure • •1), did
DOt inducea peptide-specificT<ell response(Table .... ) anddid not inducea peptlde-speeitic
IgG Ab response(FiJ ure 4.3). For these reasons., wedecidedthat the possibility of these pcptides
induciog mooonuelw- cd! in1iItntiooofthyro;d glandswas low. Of the pepUdestCSled.
Tg(2597-2609) consistently inducedth)Toiditis in all threestrains of mice(Table ".9. Figurt
4.4). Thedegree of mononuclear cellinfiltrationof thethyroid in each strain correlatedwith the
degreeofpeptide-spec:ific serumIgOIntibody response. Foreumple. CBM mice gave the
highest.antibody response(rlprt 4.3) , and they alsoshowed thehighest grade ofi ntiltrationin
the thyroids, with. mean infiltrationindexof3 .33::1: .517 (Table 4.'). This high serum ISG
antibody responsemayindicatemore CD4+ T betpcrcellsactivated , which interact with B cells
to produce antibodies. A5CD4-+- andCDS+ T cellsare involvedin the iJUtiation or EAT, this
inae&sed antibody responsemay indiC&1e that moreCD4+ T cd1s are activated by the peptide,
andthus are able to participatein the infiltrationof thyroid glands. It is alsoworthwhileto note
thai thispeptidewu found to bind relatively stronglyto A~ [Tg(2S97-2609)} (FigUft 4.1).
Table 4.9. Comparison of histology results (rom diffe rent 1I · 2 ~ mouse strains immunized with Tg
pe pl ides
Pept ide S trai n
ICso (~M) Infi ltrati on Index
__ _ _ _ __ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ ## mice Me an
N Ek 0 I 2 3 4 S with EAT 1.1 .•
~
Tg









































































Mice were immunized and thyroid glands remove d for histo logy as outlined in Materials and
Methods. IC" was calculated using competitive inhibition assay as shown in Table 4.3. Three
mice per strain per peptide were immunized and thyroid glands removed for histology . •










Mice were immunized with 100nmal Tg(2S97·2609 ) in CFA and
boosted 2t days later with SOnmol peptide in IFA. Fourteen days
after boosting, thyroid glands were collected andsectioned . stained
and scored as outlinedin Materials and Methods. Section A is normal
Ihyroid gland. infiltration index (1.1.)of 0 ; B =1.1.of I; C = 1.1 of 2. D=
1.1. of 3. all viewed at 100 x magnification. E = 1.1. of 3. a 250 x
magnification of section D.
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... DISCUSSION
Amongthe differentmethodsemployedto mapT-cd! epit0p6 in autoantigens. the use of
algorithmsis quite eommon andhu been usedto delineatepathogenic Tg epitopes(reviewed in
CaByanniolis andRao. 1997) . T cells recognize antigenicdeterminan ts of autoantigens as
peptidesassociated v.ith self-Mlle . BiDding of'imn'alnogalicpeptides10 MHCis. prerequisite
for T cdI activation(BabbiU eeaI., 1985)andT ceI1 activItion against Tg is known to lead to
EATinduction. For this reason. algorithms that screenfor peptide-binding lo MHC molecules
IDlybe belpful in identifying pathogenic peptides withinlargeantigens.
H·'1!micehavebeen sbown to be 'good respoadcn' to EATand the genetic control of
EAT basbeenmappodtc the I·A~ (lleUeI ODd Rose, 1983). n.u.T8 peptidesthol bind
to A' aregood candidates forpathogenic T-<:ell epitopes. Thealgorithm used In this srudywas
created bycompiling information on manypeptides andtheir abilityto bind either A~ or E'
molecules (Alluviaet aI., 1994) Thisalgorithmused. databaseof At. or E'-binding peptidesand
sc:arched for motifsthat were commonto thesebiDding peptides. Thesemotifs then relatedto the
sequencefeatures oCthel. a. in eachposition.such as polariry, charge.,sizeand hydrophobicity.
The computerized scanofA~.-binding peptides resultedin 3 separate motifs. designated A, B and
C. In our study, two cftbese motifs (A and B) wereusedto scantheC·tcrmin&l end of rTg.as
the sequcoceor mYg wasunknownat this time.TheICIJl of the1ul967 1.._ofrTg identified29
pcptidesthatcoat&ined~A and 11 that containedmotifS. Oftbese peptidc:s.. sevenpeptides
hadcompletciyoverlappingA andB motifswhile6 badpanially overlapping motifs (seeTable
nU). Of the ..... peptides withcompIetelyovalapping motifs, two peptideslwl been~
studied anddelennincd to be pathogmic. Thefactthat thesealgorithmsidentified two peptides
that were alreadyknownto bepathogenic(Hutchings et aI., 1992, Chronopoulou and
Canyannioti~ 1992)bighlights itsvaNein po«tictingnewpathogenic epitopes.
A subsequentscanoCthe'completemTg identified sevenmorepeptidesthat had
completelyoverlappingA andB motifs. Thesepeptidesare good Tccellepitopecandidatesin
fUtureEAT srudies. Usingthe rTg &agmeat, fiveof the sevenCOlTesponding mTS peptides
coatainedbothmotifs. In one oftbe mTSpcptides that didn' t fit, {rTg(2424-2437»). a $Llbstitution
withinthe mTg moleculeresultedin an La. that no longercorrespondedwith the motif.The
published complete scquenee afmlg (Ca!uregLi et aI., 1997)will allow. more systematicsearch
of pathogenic TSepitopes. Upto now, T<eUepitopes in murineEAThavebeen mappedusing
heterologousTgs and it is poSSIble that • singlea.a. differencein • Tscellepitope site mayabolish
itsP&Iho8cnie properties and. therefore. itsdetection by an a1gorithnDe approacll.
RcccntIy. thecrystaIsuueture ofA· basbeenrevealed. andfromchisstructure, a motiffor
peptidebindinahas beenprac:otcd (Freemomet aI., 1998)bucd on theabilityof individual • .•.
to fit withinpockets inthe A moleculesgroove. This motifspans9 La. positionsand hasIn
exclusiverequirementforaspartic acid at position1 andeither glutamineor glutamic acidat
position6 (Frecmome aI., 1998). makingit morerestrictivethanprevious motifs. WhentJUs
motifwu used to scan theLa. sequenceboth mTg and the rYg fragment. it yielded 3 and I
peptidesrespeetiveJy. These pcptidesalso corresponded with peptidesf~ conuining motif A
and B in the presentstudy. However, onlyone of the peptides synthesizedin our study,
rTg(2108-212S) aetuaIIyfit the aysuI _ mati( yet thispeptideexlubilod DO derecuble
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bindingto A~ in the competitive bindingassay (see Table ...7). This is probably due to low
peptidepurity (75%) or degradation during storage . It may also indicate a failureofltlis particular
motif
Althcugh the peptides,Tg(2424-2437) and Tg(2597 -2609) showeddetccublelMding tc
both A· andE' moleculesin the competitivebindingassay(see Figure ".1. Filure ...2, and T.ble
.c.7), andinduced specific IgO responses(Figure " .2), neitherpeptidestimulated an In vuro
proIifentive _ ofLNC &omonce~ withthatpeptide. EAT mduaioowith
TJ<2597·2609) iDdicates that it must activate effectorc:dls IS an antibody responsein<fjwesthe
presenceofT-cell help. Thus it is unclearwily thesepcptidcs did not induce I proliferativeLNC
response.
P<ptide degndalioo duringstcrage mayplay. role. For C>WIlple, preIimUwysmdi.. by
G.Carayanniotis found. strong antibody responseto rTJ( 2 10S.212S) in OH mice immunized
with thatpeptide. but this wasnot detected in subsequent studies (Flpre 0).
The present data clearlydemonstn.te that thepeptide Tg(2S97-2609) causes mouse EAT.
Althoughin vitro T cellproliferation could not bedcmonstJ'lted. it is impliedby the other resutts
The presenceof a stroog IgG responseto the peptideimpIjcs T helperactivationandthe
infiltration of thyroid glandsby mononudear ccU.s alsoindicatesthe involvement of specifically
activated effector T cells. The abilityoflhi s peptide 10 bind 10Akmolecules is compatible with its
immunogenic role. The role ofanti. Tg antibodiesin the pathogenesis orEAT is controversial
(reviewed in Tomer, 1997). In someexperiments.EAT waspassivelyuansfcrred into naivemice
by anti·TS Abs(V1adutiu etlI., 1971, Nabmura et aI., 1969,Clagen d aI., 1974, Tomazic etlI.•
1971. Polley ct at. 1981). Thissupports. role of anti-Tg antibodies.,andpossibly anti-Tg peptide
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Abs in thepathogenesisorEA T. Yet. whileEAT canbereliablyshownto be transferred using
Tg-specific T cdls.the abilityofTg·spcc:ific IgGto transferEATbasnot beenconsistently
sbown(Tomcr,l997). Forthisreuoa. AbdataindieatingTg-pepbdespcciliclgO inthesera of
miu immunized with thatpeptide. cannot indicate its pathogenesis. However. whenthisAbdata
ismergedwithdata indicar:ing infiltration of thethyroid gIancI by mononuclearcells in mice
immunized with the samepeptide, it indicatesthat this peptideis pathogenic. The racethat
antibodiesare produced indicatesbcl:p fromT cds. u does infiltration. In this study, antibody
response did correlatewith patbogencsis. Significant productionof ItIti-peptide Abs served IS an
indicatorof infiltration of thyroid glands by mononuclear cdls in micelmmunizcd with the same
peptide. However, the antlbodyresponseto thepeptidewasnot cross reactivewith mTg,
indKatingthatllIe p&lhogcnic: peptide[Tg(2S97.2609)) ;, likely. seroIog;c:aJJy nolHlominant
epitope.
This algorithmhas beensu~ in identifying peptidcs thu may bindto A' molecules.
yet not all Tg peptides predictedwere shown to bind to A' (see T.b~ 4.1). However. the Tg
peptidethatwasshown to bindstrongly A' wasalsoshownto bepathogenic wheninjectedinto
mice. In this manner, this algorithmts. successfW method to predie:tT td1 epitopes in TS.
4o!FUTURI:DIRECTIONS
Thepublishedsequence ar mTgis an asset to the mappingof pathogenicT-cellepitopes in
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"'lIriDeEAT. TheoIgoritbm used here andthemotifliom theaysuI suuctun: Jw beenused in
mTS to predict Tg peptides that maybindto A'. Thesepeptidesshould be tested for theirability
to bindto A' and itthey are shown to bind,they sboukIbetested ill H·t' micefortbeir
pathogenicity in EAT. TheE' motifsshouJdalsobeusedto predict pathogenicpeptidescf Tg.
Theseapproaches would aUow the predictionofepitopes in the N-terminalregionof the Tg
molecule.,IS to date.,most epitopcsare clusteredIt the C·tcrminalend(Carayanniotis and Rao.
1991). Thesealgorithmsmay also allowfor a dominAnt epitcpeaf Tg to be mapped.
The pathogeoicilyofTg(2597-2609) shouJdbec:oofumod byusing Tg(2S97-2609)-
speci& LNC in adoptive transferexperiments. CBM micemaybethe best prospect for these
expcrimems.,IS they wereshownto givethebest responseto thispeptide. Also, >95% pure
prepamions ofboth thepathog.... Tg(2597-2609)and Tg(2108-212S) s1IouId bemadeandthe
immune responseofmicc to thesepeptidesretested . With respect to Tg(2108-212S), earlier
work: indicated that• IUgh w e of peptide-specificIgG were producedin responseto mouse
imnI.mization withthis peptide,but subsequcm experiments failed10 rqmxIuccthis. Thispeptide
was also predictedas an A'·binderbythe crystalstructure motif;yet competitive binding assays
failed to indicatebinciing to A'. N the peptideprepantion may DOt bepureenough, or it may
bavedegraded over time. freshpeptideshouldbeused to immunize mice beforeconcludingthat
it is nOI • pathogenicepitope.
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